N-CSR 1 d794102dncsr.htm ISHARES U.S. ETF TRUST iShares U.S. ETF Trust

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number   811-22649                                                                                                                                            

 

iShares U.S. ETF Trust

(Exact name of registrant as specified in charter)                            

c/o: State Street Bank and Trust Company

  

100 Summer Street, 4th Floor, Boston, MA

                                            02110

(Address of principal executive offices)

                                            (Zip code)

The Corporation Trust Company

1209 Orange Street, Wilmington, DE 19801

 

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:        (415) 670-2000                    

Date of fiscal year end:

     July 31, 2019                       

Date of reporting period:

     July 31, 2019                       


Item 1.      Reports to Stockholders.

Copies of the annual reports transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 are attached.


JULY 31, 2019

 

2019 ANNUAL REPORT

  LOGO

iShares U.S. ETF Trust

 

   

iShares Evolved U.S. Consumer Staples ETF  |  IECS  |  Cboe BZX

 

   

iShares Evolved U.S. Discretionary Spending ETF  |  IEDI  |  Cboe BZX

 

   

iShares Evolved U.S. Financials ETF  |  IEFN  |  Cboe BZX

 

   

iShares Evolved U.S. Healthcare Staples ETF  |  IEHS  |  Cboe BZX

 

   

iShares Evolved U.S. Innovative Healthcare ETF  |  IEIH  |  Cboe BZX

 

   

iShares Evolved U.S. Media and Entertainment ETF  |  IEME  |  Cboe BZX

 

   

iShares Evolved U.S. Technology ETF  |  IETC  |  Cboe BZX

 

 

Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of each Fund’s shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from your financial intermediary, such as a broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.

You may elect to receive all future reports in paper free of charge. If you hold accounts through a financial intermediary, you can follow the instructions included with this disclosure, if applicable, or contact your financial intermediary to request that you continue to receive paper copies of your shareholder reports. Please note that not all financial intermediaries may offer this service. Your election to receive reports in paper will apply to all funds held with your financial intermediary.

If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive electronic delivery of shareholder reports and other communications by contacting your financial intermediary. Please note that not all financial intermediaries may offer this service.

 


Table of Contents

 

      Page  

Market Overview

     3  

Fund Summary

     4  

About Fund Performance

     18  

Shareholder Expenses

     18  

Schedules of Investments

     19  

Financial Statements

  

Statements of Assets and Liabilities

     40  

Statements of Operations

     42  

Statements of Changes in Net Assets

     44  

Financial Highlights

     48  

Notes to Financial Statements

     55  

Report of Independent Registered Public Accounting Firm

     63  

Important Tax Information (Unaudited)

     64  

Board Review and Approval of Investment Advisory Contract

     65  

Supplemental Information

     68  

Trustee and Officer Information

     71  

General Information

     73  

Glossary of Terms Used in this Report

     74  

 

 

       


Market Overview

 

iShares U.S. ETF Trust

Domestic Market Overview

The 12 months ended July 31, 2019 (“reporting period”) featured significant U.S. stock market volatility, as large-capitalization equities ended near record highs, while small-capitalization stocks declined. For the reporting period, the Russell 3000 Index, a broad measure of U.S. equity market performance, rose 7.05%, while the Russell 2000 Index of small-company stocks returned -4.42%. In addition, the S&P 500 declined the most in any December since the Great Depression, and calendar year 2018 was the worst full year since 2008. However, the subsequent recovery meant that the first six months of 2019 were the strongest start to a year since 1997.

The volatility was a function of changing economic growth, interest rates, corporate profits, and political conditions. In terms of the economy, the rate of growth slowed over the course of the reporting period to a 2.1% annualized rate during the second quarter of 2019. That was down from 3.5% the previous year. Industrial production declined from a 5.4% annual rate in September 2018 to 1.3% rate year-over-year through June 2019, and manufacturing growth in June 2019 was the slowest since late 2016. In the consumer segment of the economy, retail sales slowed from a 6.6% annual pace in July 2018 to 3.4% in June 2019 after reaching a low of 1.4% in December 2018.

Slowing economic growth caused a change in bond yields and the U.S. Federal Reserve Bank (“Fed”) interest rate policy. In early December 2018, a portion of the yield curve (a graphic representation of bond yields at different maturities) inverted for the first time since 2005. Investors took this as a sign that recession was imminent, exacerbating concerns about the economy and corporate profits. Similarly, concerns about the economy led to a change in the Fed’s interest rate policy. For example, the Fed increased rates four times in calendar year 2018, once each during September and December. The stock market was at a record high in early October 2018 when the Fed Chairman seemed to argue for more interest rate increases than expected, precipitating a sell-off. The final interest rate increase came amid the stock market decline, as the Fed cited strong growth in employment and economic activity. But by January 2019, the market decline and slowing growth caused the Fed’s view to change. Consequently, the Fed decreased rates in July 2019 for the first time since 2008.

Another significant contributor to market turmoil was uncertainty resulting from the ongoing trade conflict between the U.S. and China. The uncertainty caused by the government shutdown also weighed on market sentiment, as investors were concerned about the potential economic impacts of government policy mistakes.

The slowdown in economic growth also affected corporate profits. Corporate earnings growth turned negative in the first quarter of 2019 and again in the second quarter, for the companies in the S&P 500 that had reported earnings through July 2019. The last time the earnings growth for the Index was negative for two consecutive quarters was the first and second quarter of 2016.

Growth-oriented stocks outperformed value at all capitalization ranges. Stocks of large companies outperformed those of mid- and small-sized companies, which performed particularly poorly in the fourth quarter of 2018.

 

 

MARKET OVERVIEW      3  


Fund Summary  as of July 31, 2019    iShares® Evolved U.S. Consumer Staples ETF

 

Investment Objective

The iShares Evolved U.S. Consumer Staples ETF (the “Fund”) seeks to provide access to U.S. companies with consumer staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    14.23      12.13       14.23      16.91

Fund Market

    14.26        12.19         14.26        16.99  

S&P Total Market IndexTM

    6.91        8.51               6.91        11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,139.40        $ 0.95             $ 1,000.00        $ 1,023.90        $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

4    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Consumer Staples ETF

 

Portfolio Management Commentary

Consumer staples stocks advanced for the reporting period, as the consumer segment of the economy remained strong despite a more general decrease in economic growth. Consumer spending held up reasonably well despite the broader economic slowdown, supported by solid income growth and strength in the job market. Concerns about the health of the economy also increased the appeal of the sector, whose earnings tend to be resilient during economic slowdowns.

Household products and beverages companies were among the largest contributors to the Fund’s performance. Procter & Gamble Co., a household products conglomerate, benefited from strong consumer demand and price increases for some of its leading brands. Business was buoyed by the effective use of technology to improve product innovation and distribution. Among beverage stocks, the Coca-Cola Company and PepsiCo, Inc. were significant contributors. Coca-Cola’s growth was driven by its sugar-free Coke Zero, water, enhanced water, and sports drinks product lines, as consumers moved away from high-sugar products. PepsiCo benefited from diversifying its business into snack foods, energy drinks, and sparkling water. Packaged foods and meats companies were another source of strength. Mondelez International, Inc. benefited from strong demand for its snack foods in emerging markets and succeeded in passing on higher input costs to consumers.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer staples companies that traditionally have been categorized in sectors other than consumer staples. For example, the process classified restaurants Starbucks Corporation and McDonald’s Corporation, which are typically categorized in the consumer discretionary sector, as having significant exposure to both discretionary spending and recurring spending on consumer staples. As a result, the portion of the market capitalization that the process recognized as consumer staples was included in the Fund. These restaurants were strong contributors to the Fund’s return for the reporting period, as healthy consumer spending and innovations such as mobile payment, customer loyalty programs, and delivery services increased accessibility and drove transaction growth.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments
 
(a) 

Beverages

    26.6

Food

    25.5  

Retail

    15.4  

Agriculture

    10.9  

Cosmetics & Personal Care

    10.8  

Household Products & Wares

    2.6  

Packaging & Containers

    2.5  

Pharmaceuticals

    2.1  

Chemicals

    1.6  

Other (each representing less than 1%)

    2.0  

 

  (a) 

Excludes money market funds.

 

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

Coca-Cola Co. (The)

    10.5

PepsiCo Inc.

    9.0  

Procter & Gamble Co. (The)

    7.7  

Starbucks Corp.

    5.0  

Philip Morris International Inc.

    4.9  

McDonald’s Corp.

    4.8  

Mondelez International Inc., Class A

    4.6  

Altria Group Inc.

    3.8  

General Mills Inc.

    3.1  

Colgate-Palmolive Co.

    2.7  
 

 

 

FUND SUMMARY      5  


Fund Summary  as of July 31, 2019     iShares® Evolved U.S. Discretionary Spending ETF

 

Investment Objective

The iShares Evolved U.S. Discretionary Spending ETF (the “Fund”) seeks to provide access to U.S. companies with discretionary spending exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    11.73      14.73       11.73      20.62

Fund Market

    11.81        14.76         11.81        20.66  

S&P Total Market IndexTM

    6.91        8.51               6.91        11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
      

Annualized
Expense
Ratio
 
 
 
 $ 1,000.00         $ 1,122.40         $ 0.95              $ 1,000.00         $ 1,023.90         $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

6    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Discretionary Spending ETF

 

Portfolio Management Commentary

Stocks tied to discretionary spending advanced for the reporting period, as the consumer segment of the economy held up well despite a broader slowdown in economic growth. Consumer spending remained relatively healthy, supported by solid income growth and strength in the job market. A key factor that was evident during the reporting period was the blending or breakdown of the distinction between brick-and-mortar and e-commerce retail, as retailers increasingly relied on multi-channel distribution to reach customers. This represents the latest step in the evolution of retail, as a number of less-competitive brands and retailers filed for bankruptcy or closed locations, while such technology-savvy companies as Apple Inc. and Amazon.com, Inc. invested heavily in retail outlets and strategy.

Restaurants were the largest contributor to the Fund’s return. Both Starbucks Corporation and McDonald’s Corporation advanced due to healthy consumer spending and innovations such as mobile payments, customer loyalty programs, and delivery services, which increased accessibility and drove transaction growth. As foot traffic decreased due to online shopping, these companies reaped the benefits of remaking their in-store experience and enhancing productivity with technology.

Specialty retailers were another source of strength, reflecting gains by The Home Depot, Inc. and AutoZone, Inc. Home Depot posted solid earnings growth amid strong demand from contractors and retail customers engaged in home-improvement projects. Automotive parts retailer AutoZone benefited from a slowdown in new car sales, which supported demand for auto parts as vehicles age.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer discretionary companies that have traditionally been categorized in other sectors. For example, the process grouped a number of consumer staples companies in the consumer discretionary sector, including household products company The Procter & Gamble Company, and food and staples retailer Walmart Inc. Proctor & Gamble benefited from strong consumer demand and price increases for some of its leading brands. Business was buoyed by more effective use of technology to improve product innovation and distribution. Emblematic of the blending of e-commerce with traditional retail, Walmart’s ongoing investment in technology and its online presence led to sharp growth in its online business during the reporting period.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments
 
(a) 

Retail

    54.5

Internet

    16.1  

Apparel

    7.6  

Cosmetics & Personal Care

    6.0  

Computers

    4.2  

Lodging

    3.0  

Commercial Services

    1.4  

Food

    1.3  

Leisure Time

    1.2  

Distribution & Wholesale

    1.1  

Other (each representing less than 1%)

    3.6  

 

  (a) 

Excludes money market funds.

 

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

Amazon. com Inc.

    13.0

Home Depot Inc. (The)

    8.4  

Walmart Inc.

    6.2  

Procter & Gamble Co. (The)

    4.8  

Costco Wholesale Corp.

    4.5  

Apple Inc.

    4.2  

McDonald’s Corp.

    3.9  

NIKE Inc., Class B

    3.8  

TJX Companies Inc. (The)

    2.9  

Lowe’s Companies Inc.

    2.6  
 

 

 

FUND SUMMARY      7  


Fund Summary  as of July 31, 2019     iShares® Evolved U.S. Financials ETF

 

Investment Objective

The iShares Evolved U.S. Financials ETF (the “Fund”) seeks to provide access to U.S. companies with financials exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year     Since
Inception
           1 Year     Since
Inception
 

Fund NAV

    3.64 %(a)      1.60       3.64 %(a)      2.20

Fund Market

    3.68       1.60         3.68       2.19  

S&P Total Market IndexTM

    6.91       8.51               6.91       11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

 

  (a) 

The NAV total return presented in the table for the one-year period differs from the same period return disclosed in the financial highlights. The total return in the financial highlights is calculated in the same manner but differs due to certain adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
      

Annualized
Expense
Ratio
 
 
 
 $ 1,000.00         $ 1,110.80         $ 0.94              $ 1,000.00         $ 1,023.90         $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

8    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Financials ETF

 

Portfolio Management Commentary

Financials stocks advanced for the reporting period, as financial technology (“fintech”) companies performed well in an environment that was challenging for more traditional financial institutions. As commerce increasingly migrates online and mobile technology continues to proliferate, fintech stocks benefited from the move away from checks and cash toward online and mobile payment systems. In contrast, banks performed poorly, as a flattening yield curve (the difference between short-term and long-term interest rates) reduced loan profitability and a slowing economy raised fears about reduced demand for financial services.

Reflecting the relative strength of fintech companies, the leading contributor to the Fund’s performance was data processing companies. Mastercard Incorporated, a leading credit card and payment processing company, benefited from the shift towards online payments, which drove strong growth in revenue and profitability. Another payment processor, Worldpay, Inc., gained after becoming targeted for acquisition by Fidelity National Information Services, Inc., which was also a leading contributor to the Fund. Investors anticipated that the acquisition would improve revenue while reducing costs by employing efficiencies of scale. Insurance companies also contributed to the Index’s performance, particularly property and casualty insurers. For example, The Progressive Corporation posted gains after growing its portfolio of written premiums and posting a high underwriting margin, a measure of profitability.

On the downside, regional banks were significant detractors from the Fund’s return, as smaller banks struggled with the investments required for digitization and modernization of online services. SVB Financial Group, which specializes in lending to venture capital companies from Silicon Valley, declined as investors became concerned about banks with higher risk profiles amid the economic slowdown. Comerica Incorporated also detracted from the Index’s performance, pressured by low interest rates following the Fed’s move toward looser monetary policy.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. As of the end of the reporting period, the Fund’s portfolio consisted primarily of financials stocks, but also included companies in diverse industries such as data processing and outsourced services and application software. For example, Mastercard provides credit card services to banks, and Automatic Data Processing, Inc. creates outsourced human resource management services for businesses.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments

(a) 

Banks

    44.3

Insurance

    25.3  

Diversified Financial Services

    16.9  

Commercial Services

    4.7  

Software

    2.6  

Health Care - Services

    2.5  

Savings & Loans

    1.5  

Other (each representing less than 1%)

    2.2  

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

Bank of America Corp.

    4.6

JPMorgan Chase & Co.

    4.6  

Wells Fargo & Co.

    4.5  

Citigroup Inc.

    4.2  

U. S. Bancorp.

    3.0  

Berkshire Hathaway Inc., Class B

    2.5  

Goldman Sachs Group Inc. (The)

    2.3  

American Express Co.

    2.2  

Morgan Stanley

    1.8  

Mastercard Inc., Class A

    1.8  
 

 

  (a) 

Excludes money market funds.

 

 

 

FUND SUMMARY      9  


Fund Summary  as of July 31, 2019    iShares® Evolved U.S. Healthcare Staples ETF

 

Investment Objective

The iShares Evolved U.S. Healthcare Staples ETF (the “Fund”) seeks to provide access to U.S. companies with healthcare staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year     

Since

Inception

           1 Year     

Since

Inception

 

Fund NAV

    8.77      14.64       8.77      20.49

Fund Market

    8.85        14.64         8.85        20.49  

S&P Total Market IndexTM

    6.91        8.51               6.91        11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,046.00        $ 0.91             $ 1,000.00        $ 1,023.90        $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

10    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Healthcare Staples ETF

 

Portfolio Management Commentary

U.S. healthcare staples stocks posted strong gains during the reporting period, benefiting from the expansion of an aging population, which led to greater demand for and increased spending on healthcare-related products, services, and facilities. Higher enrollment in healthcare coverage through the Affordable Care Act also bolstered utilization of healthcare services.

Healthcare equipment manufacturers were the largest and primary contributors to the Fund’s return amid ongoing innovation by companies making specialized equipment for the treatment of chronic illnesses. Abbott Laboratories was a noteworthy example, gaining amid increased adoption of treatments using minimally invasive, continuous monitoring technologies for conditions such as diabetes. Several healthcare equipment manufacturers benefited from the growing market for treating diseases and conditions related to growing older. For example, Edwards Lifescience Corp and Medtronic plc advanced due to rising demand for products used to treat coronary disease, such as heart valve replacements and coronary stents, while rising sales of surgical equipment and bio-implant devices, such as artificial joints, supported companies such as Stryker Corp.

Life sciences companies were modest, although meaningful, contributors. Strong global demand for genetic sequencing technologies used in areas such as diagnostics and research bolstered returns of scientific instruments makers like Thermo Fisher Scientific. Clinical research organizations like Iqvia that work with biotechnology companies to develop new treatments were also noteworthy contributors. The temporary suspension of a medical device tax, followed by a Congressional bid to entirely overturn the legislation, was also advantageous to medical device companies. Managed healthcare providers like Anthem Inc. benefited from higher enrollment in healthcare coverage and rising demand for Medicare Advantage plans.

The fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activities. More specifically, the evolved investment process identified several companies with healthcare-related businesses. One example, Welltower Inc., which owns hospitals, senior living facilities, and other healthcare-related properties, performed well as the aging population in the U.S. drove demand for healthcare facilities and services.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments
 
(a) 

Health Care - Products

    47.6

Health Care - Services

    29.4  

Pharmaceuticals

    10.9  

Biotechnology

    3.3  

Real Estate Investment Trusts

    2.7  

Electronics

    1.4  

Commercial Services

    1.1  

Software

    1.1  

Other (each representing less than 1%)

    2.5  

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

UnitedHealth Group Inc.

    11.2

Medtronic PLC

    7.1  

Abbott Laboratories

    6.7  

Anthem Inc.

    3.4  

Thermo Fisher Scientific Inc.

    3.3  

Intuitive Surgical Inc.

    3.3  

Stryker Corp.

    3.2  

Becton Dickinson and Co.

    3.2  

Danaher Corp.

    3.1  

Boston Scientific Corp.

    3.0  
 

 

  (a) 

Excludes money market funds.

 

 

 

FUND SUMMARY      11  


Fund Summary  as of July 31, 2019    iShares® Evolved U.S. Innovative Healthcare ETF

 

Investment Objective

The iShares Evolved U.S. Innovative Healthcare ETF (the “Fund”) seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    (3.04 )%       1.05       (3.04 )%       1.43

Fund Market

    (2.97      1.08         (2.97      1.47  

S&P Total Market IndexTM

    6.91        8.51               6.91        11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period 
 
 
(a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 979.10        $ 0.88             $ 1,000.00        $ 1,023.90        $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

12    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Innovative Healthcare ETF

 

Portfolio Management Commentary

U.S. innovative healthcare stocks declined for the reporting period, amid ongoing concerns about the future structure of the U.S. healthcare system. With pressure for universal healthcare and lower drug prices mounting as the 2020 presidential race began, stock prices of many healthcare-related companies declined.

The Fund’s performance was driven primarily by biotechnology stocks, which faced a number of headwinds, including several disappointing clinical trial results. For example, biotechnology company Biogen Inc. declined sharply after revealing it would discontinue two late-stage trials for an Alzheimer’s disease treatment, which was considered the treatment with the highest potential in the company’s pipeline. Regeneron Pharmaceuticals Inc. also faced setbacks during clinical research due to several patient deaths during its non-Hodgkin lymphoma drug trial. Many biotechnology companies also weakened amid market share losses to biosimilars and generic versions of name-brand drugs, with companies such as AbbVie Inc. and Gilead Sciences Inc. declining under competitive pressure. A wave of initial public offerings also pressured the stocks of industry leaders as investors shifted capital to new healthcare ventures.

On the upside, several healthcare equipment and supplies stocks contributed meaningfully, supported by the development of innovative new technologies. For example, companies like Abbott Laboratories and Dexcom Inc. benefited from growing adoption of treatments employing minimally invasive, continuous monitoring technologies for conditions such as diabetes. Pharmaceuticals stocks also advanced. For example, pharmaceuticals stocks such as Merck & Co. Inc. and Eli Lilly & Co. benefited from strong demand for medications to treat diseases such as cancer and diabetes, and rising sales of vaccines amid a resurgence of preventable diseases such as measles.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. As of the end of the reporting period, the Fund’s portfolio consisted primarily of biotechnology and pharmaceuticals companies that emphasize innovation, but also included companies in diverse industries such as life sciences tools and services and semiconductors. One example is Universal Display Corp, which makes organic light emitting diodes that are used in medical imaging and diagnostics equipment. The company posted sharply higher revenues, driven by strong demand from Chinese customers.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments
 
(a) 

Pharmaceuticals

    52.8

Biotechnology

    39.9  

Health Care - Products

    5.7  

Health Care - Services

    1.2  

Other (each representing less than 1%)

    0.4  

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

Johnson & Johnson

    11.1

Merck & Co. Inc.

    8.2  

Pfizer Inc.

    7.0  

Amgen Inc.

    4.9  

Eli Lilly & Co.

    4.7  

Celgene Corp.

    4.6  

Gilead Sciences Inc.

    4.3  

Bristol-Myers Squibb Co.

    4.2  

Vertex Pharmaceuticals Inc.

    4.0  

AbbVie Inc.

    3.8  
 

 

  (a)

Excludes money market funds.

 

 

 

FUND SUMMARY      13  


Fund Summary  as of July 31, 2019    iShares® Evolved U.S. Media and Entertainment ETF

 

Investment Objective

The iShares Evolved U.S. Media and Entertainment ETF (the “Fund”) seeks to provide access to U.S. companies with media and entertainment exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    8.64      10.54       8.64      14.65

Fund Market

    8.67        10.57         8.67        14.69  

S&P Total Market IndexTM

    6.91        8.51               6.91        11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSETVALUE)

 

  LOGO  

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,106.40        $ 0.94             $ 1,000.00        $ 1,023.90        $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

14    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Media and Entertainment ETF

 

Portfolio Management Commentary

U.S. media and entertainment stocks advanced for the reporting period, as demand for original entertainment and high-speed internet offset losses from customers migrating away from traditional cable plans. Higher advertising revenues and licensing fees bolstered returns, and large investments in new programming drove increases in the subscriber base. Video streaming continued to grow in popularity, with over half of U.S. households subscribing to at least one streaming service as options for digital delivery proliferated.

The Walt Disney Company was the largest single contributor to the Fund’s return, driven by strength in its theme park business and the popularity of its movies, which included the highest-grossing movie in cinema history. Investors were also optimistic about the future of the Disney+ streaming service, which was announced during the reporting period and is scheduled to launch in late 2019. Comcast was also a standout performer, buoyed by strong growth in its internet business and its forthcoming streaming service for NBCUniversal Media, LLC. Increased demand for internet services also benefited cable and internet provider Charter Communications, Inc., which grew revenues from both residential and commercial customers. Sinclair Broadcast Group also contributed amid higher advertising revenues and investor enthusiasm surrounding its acquisition of 21 regional sports networks.

On the downside, video game makers were the leading detractors from the Fund’s performance, pressured by competition from popular free-to-play games. Activision Blizzard, Inc. dropped on a year-over-year decrease in monthly active users and lower revenue from in-game spending. Another games company, Electronic Arts Inc., experienced disappointing performance due to poor performances from games such as FIFA 19, Anthem, and Apex Legends.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. As of the end of the reporting period, the Fund’s portfolio consisted primarily of media and entertainment companies, but also included companies in diverse industries such as leisure products and research and consulting services. For example, Hasbro, Inc., in addition to manufacturing toys, sells popular games such as Magic: The Gathering, and the company benefits from notable entertainment properties such as Transformers, Power Rangers, and My Little Pony. Hasbro was a solid contributor to the Fund’s performance for the reporting period.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments
 
(a) 

Media

    59.8

Internet

    14.8  

Software

    9.1  

Entertainment

    6.2  

Toys, Games & Hobbies

    3.5  

Commercial Services

    1.9  

Lodging

    1.0  

Other (each representing less than 1%)

    3.7  

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

Walt Disney Co. (The)

    7.0

Comcast Corp., Class A

    6.3  

Charter Communications Inc., Class A

    5.2  

CBS Corp., Class B

    4.5  

Viacom Inc., Class B

    4.1  

Netflix Inc.

    4.1  

Activision Blizzard Inc.

    3.9  

Discovery Inc., Class C

    3.3  

Twitter Inc.

    3.1  

Electronic Arts Inc.

    3.0  
 

 

  (a) 

Excludes money market funds.

 

 

 

FUND SUMMARY      15  


Fund Summary  as of July 31, 2019    iShares® Evolved U.S. Technology ETF

 

Investment Objective

The iShares Evolved U.S. Technology ETF (the “Fund”) seeks to provide access to U.S. companies with technology exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      Since
Inception
           1 Year      Since
Inception
 

Fund NAV

    15.27      15.82       15.27      22.19

Fund Market

    15.38        15.94         15.38        22.35  

S&P Total Market IndexTM

    6.91        8.51               6.91        11.73  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSETVALUE)

 

  LOGO  

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market IndexTM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 18 for more information.

Expense Example

 

Actual           Hypothetical 5% Return           
 

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
           

Beginning
Account Value
(02/01/19)
 
 
 
      

Ending
Account Value
(07/31/19)
 
 
 
      

Expenses
Paid During
the Period
 
 
 (a) 
      

Annualized
Expense
Ratio
 
 
 
$ 1,000.00        $ 1,188.30        $ 0.98             $ 1,000.00        $ 1,023.90        $ 0.90          0.18

 

  (a) 

Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days) and divided by the number of days in the year (365 days). See “Shareholder Expenses” on page 18 for more information.

 

 

 

16    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Fund Summary  as of July 31, 2019 (continued)    iShares® Evolved U.S. Technology ETF

 

Portfolio Management Commentary

The Fund advanced significantly during the reporting period, reflecting overall strength in the information technology sector, which advanced due to continued investment in information technology infrastructure. The sector showed resilience despite concerns about possible interventions by regulators in the U.S. and possible effects of trade tensions between the U.S. and China, including restrictions on the sale of chips to Chinese companies. The sector also benefited from the rapid migration of information technology to the cloud for both storage and software.

Software and services stocks contributed the majority of the Fund’s return for the reporting period, as businesses adopting cloud computing sought efficiency gains and to update aging software. Companies such as Microsoft Corporation are among the primary beneficiaries of increased adoption of cloud computing, along with other systems software companies, such as Oracle Corporation and ServiceNow, Inc. The move toward subscription-based software drove profitability by providing consistent revenues while reducing training costs. Application software stocks such as Adobe Inc. and Intuit Inc. also contributed to the Fund’s return, driven by increasing demand for cloud-based applications, particularly from small businesses attracted to lower upfront costs. IT services companies, particularly data processing companies such as Visa Inc. and Mastercard Incorporated, contributed to the Fund’s performance, as they increased their use of digital technologies to facilitate cashless payments. Hardware companies also contributed, led by companies such as Apple Inc., which contributed the most to the Fund’s return. Although smartphone sales declined, demand for Apple’s services and wearable products grew.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. The evolved process identified several information technology companies with similar businesses that have traditionally been categorized in other sectors. For example, the evolved process recognized that Facebook, Inc., a communication services sector company, had some business segments related to communications, but also had significant exposure to the information technology sector. As a result, the portion of the market capitalization that the process recognized as information technology was included in the Fund. The company, which announced their cryptocurrency project built on blockchain technology during the reporting period, advanced as customers increased their use of the site, leading to increased revenue from mobile advertising.

Portfolio Information

 

ALLOCATION BY SECTOR

 

Sector

   
Percent of
Total Investments
 
(a) 

Software

    31.0

Internet

    26.6  

Computers

    14.8  

Semiconductors

    9.0  

Diversified Financial Services

    6.7  

Commercial Services

    4.8  

Telecommunications

    4.2  

Other (each representing less than 1%)

    2.9  

TEN LARGEST HOLDINGS

 

Security

   
Percent of
Total Investments
 
(a) 

Microsoft Corp.

    15.8

Apple Inc.

    9.0  

Amazon. com Inc.

    7.2  

Facebook Inc., Class A

    5.8  

Alphabet Inc., Class C

    4.6  

Alphabet Inc., Class A

    4.5  

Cisco Systems Inc.

    3.5  

Visa Inc., Class A

    3.2  

Mastercard Inc., Class A

    2.3  

Oracle Corp.

    2.2  
 

 

  (a) 

Excludes money market funds.

 

 

 

FUND SUMMARY      17  


About Fund Performance

 

Past performance is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end is available at www.iShares.com. Performance results assume reinvestment of all dividends and capital gain distributions and do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. The investment return and principal value of shares will vary with changes in market conditions. Shares may be worth more or less than their original cost when they are redeemed or sold in the market. Performance for certain funds may reflect a waiver of a portion of investment advisory fees. Without such a waiver, performance would have been lower.

Net asset value or “NAV” is the value of one share of a fund as calculated in accordance with the standard formula for valuing mutual fund shares. The price used to calculate market return (“Market Price”) is determined by using the midpoint between the highest bid and the lowest ask on the primary stock exchange on which shares of a fund are listed for trading, as of the time that such fund’s NAV is calculated. Since shares of a fund may not trade in the secondary market until after the fund’s inception, for the period from inception to the first day of secondary market trading in shares of the fund, the NAV of the fund is used as a proxy for the Market Price to calculate market returns. Market and NAV returns assume that dividends and capital gain distributions have been reinvested at Market Price and NAV, respectively.

An index is a statistical composite that tracks a specified financial market or sector. Unlike a fund, an index does not actually hold a portfolio of securities and therefore does not incur the expenses incurred by a fund. These expenses negatively impact fund performance. Also, market returns do not include brokerage commissions that may be payable on secondary market transactions. If brokerage commissions were included, market returns would be lower.

Shareholder Expenses

As a shareholder of your Fund, you incur two types of costs: (1) transaction costs, including brokerage commissions on purchases and sales of fund shares and (2) ongoing costs, including management fees and other fund expenses. The expense example, which is based on an investment of $1,000 invested at the beginning of the period (or from the commencement of operations if less than 6 months) and held through the end of the period, is intended to help you understand your ongoing costs (in dollars and cents) of investing in your Fund and to compare these costs with the ongoing costs of investing in other funds.

Actual Expenses — The table provides information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. To estimate the expenses that you paid on your account over the period, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number under the heading entitled “Expenses Paid During the Period.”

Hypothetical Example for Comparison Purposes — The table also provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of fund shares. Therefore, the hypothetical examples are useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

 

18    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  

July 31, 2019

  

iShares® Evolved U.S. Consumer Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Advertising — 0.1%  

Omnicom Group Inc.

    48     $ 3,851  
   

 

 

 
Agriculture — 10.8%  

Altria Group Inc.

    3,313       155,943  

Archer-Daniels-Midland Co.

    1,483       60,922  

Bunge Ltd.

    348       20,334  

Darling Ingredients Inc.(a)(b)

    261       5,306  

Philip Morris International Inc.

    2,409       201,416  

Universal Corp./VA

    63       3,748  

Vector Group Ltd.

    107       1,236  
   

 

 

 
      448,905  
Beverages — 26.5%  

Boston Beer Co. Inc. (The), Class A, NVS(a)

    18       7,062  

Brown-Forman Corp., Class A

    156       8,324  

Brown-Forman Corp., Class B, NVS

    922       50,535  

Coca-Cola Co. (The)

    8,236       433,461  

Coca-Cola Consolidated Inc.

    16       4,696  

Constellation Brands Inc., Class A

    374       73,611  

Keurig Dr Pepper Inc.

    772       21,724  

MGP Ingredients Inc.

    33       1,650  

Molson Coors Brewing Co., Class B

    450       24,295  

Monster Beverage Corp.(a)

    1,525       98,317  

National Beverage Corp.

    45       1,959  

PepsiCo Inc.

    2,892       369,626  
   

 

 

 
      1,095,260  
Chemicals — 1.6%  

Balchem Corp.

    33       3,387  

Ecolab Inc.

    139       28,041  

International Flavors & Fragrances Inc.

    209       30,094  

Sensient Technologies Corp.

    72       4,908  
   

 

 

 
      66,430  
Commercial Services — 0.1%  

Medifast Inc.

    17       1,898  

Weight Watchers International Inc.(a)

    54       1,169  
   

 

 

 
      3,067  
Cosmetics & Personal Care — 10.8%  

Colgate-Palmolive Co.

    1,553       111,412  

Coty Inc., Class A

    293       3,197  

Edgewell Personal Care Co.(a)

    75       2,282  

Estee Lauder Companies Inc. (The), Class A

    61       11,235  

Procter & Gamble Co. (The)

    2,690       317,528  
   

 

 

 
      445,654  
Distribution & Wholesale — 0.1%  

Core-Mark Holding Co. Inc.

    69       2,583  
   

 

 

 
Diversified Financial Services — 0.3%  

CME Group Inc.

    61       11,859  

Jefferies Financial Group Inc.

    114       2,432  
   

 

 

 
      14,291  
Electric — 0.3%  

Entergy Corp.

    111       11,724  
   

 

 

 
Electrical Components & Equipment — 0.1%  

Energizer Holdings Inc.

    84       3,535  
   

 

 

 
Food — 25.3%  

B&G Foods Inc.(b)

    231       4,223  

Calavo Growers Inc.

    33       2,919  
Security   Shares     Value  
Food (continued)  

Cal-Maine Foods Inc.

    60     $ 2,386  

Campbell Soup Co.

    639       26,416  

Conagra Brands Inc.

    1,731       49,974  

Dean Foods Co.

    243       352  

Flowers Foods Inc.

    357       8,461  

Fresh Del Monte Produce Inc.

    50       1,517  

General Mills Inc.

    2,389       126,880  

Hain Celestial Group Inc. (The)(a)

    312       6,792  

Hershey Co. (The)

    540       81,940  

Hormel Foods Corp.

    812       33,284  

Hostess Brands Inc.(a)

    195       2,753  

Ingredion Inc.

    171       13,217  

J&J Snack Foods Corp.

    39       7,248  

JM Smucker Co. (The)

    410       45,588  

John B Sanfilippo & Son Inc.

    27       2,347  

Kellogg Co.

    988       57,521  

Kraft Heinz Co. (The)

    2,545       81,465  

Lamb Weston Holdings Inc.

    402       26,982  

Lancaster Colony Corp.

    51       7,947  

McCormick & Co. Inc./MD, NVS

    350       55,489  

Mondelez International Inc., Class A

    3,566       190,745  

Performance Food Group Co.(a)

    138       6,051  

Pilgrim’s Pride Corp.(a)

    90       2,435  

Post Holdings Inc.(a)

    219       23,481  

Sanderson Farms Inc.

    36       4,717  

Simply Good Foods Co. (The)(a)

    126       3,431  

Sprouts Farmers Market Inc.(a)

    135       2,286  

Sysco Corp.

    1,065       73,027  

Tootsie Roll Industries Inc.

    43       1,606  

TreeHouse Foods Inc.(a)

    192       11,393  

Tyson Foods Inc., Class A

    876       69,642  

U.S. Foods Holding Corp.(a)

    357       12,627  

United Natural Foods Inc.(a)

    66       651  
   

 

 

 
      1,047,793  
Food Service — 0.1%  

Aramark

    107       3,872  
   

 

 

 
Health Care – Services — 0.0%  

Tivity Health Inc.(a)

    9       157  
   

 

 

 
Household Products & Wares — 2.6%  

ACCO Brands Corp.

    93       910  

Central Garden & Pet Co., Class A, NVS(a)

    39       1,075  

Church & Dwight Co. Inc.

    329       24,820  

Clorox Co. (The)

    149       24,227  

Helen of Troy Ltd.(a)

    23       3,410  

Kimberly-Clark Corp.

    370       50,191  

Spectrum Brands Holdings Inc.

    21       1,052  
   

 

 

 
      105,685  
Housewares — 0.2%  

Newell Brands Inc.

    149       2,114  

Scotts Miracle-Gro Co. (The)

    42       4,712  

Tupperware Brands Corp.

    48       735  
   

 

 

 
      7,561  
Machinery — 0.3%  

AGCO Corp.

    69       5,313  

Middleby Corp. (The)(a)

    51       6,853  
   

 

 

 
      12,166  
Manufacturing — 0.2%  

AptarGroup Inc.

    27       3,267  
 

 

 

SCHEDULE OF INVESTMENTS      19  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Consumer Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Manufacturing (continued)  

John Bean Technologies Corp.

    36     $ 4,272  
   

 

 

 
      7,539  
Packaging & Containers — 2.5%            

Amcor PLC(a)

    688       7,293  

Ball Corp.

    713       50,965  

Berry Global Group Inc.(a)

    132       5,946  

Crown Holdings Inc.(a)(b)

    274       17,539  

Owens-Illinois Inc.

    234       3,971  

Packaging Corp. of America

    39       3,938  

Sealed Air Corp.

    78       3,259  

Silgan Holdings Inc.

    111       3,337  

Sonoco Products Co.

    126       7,564  
   

 

 

 
      103,812  
Pharmaceuticals — 2.0%            

Elanco Animal Health Inc.(a)

    362       11,932  

Herbalife Nutrition Ltd.(a)

    137       5,620  

Neogen Corp.(a)

    81       5,783  

Perrigo Co. PLC

    40       2,160  

Prestige Consumer Healthcare Inc.(a)

    66       2,284  

Zoetis Inc.

    493       56,641  
   

 

 

 
      84,420  
Real Estate Investment Trusts — 0.1%            

Americold Realty Trust

    159       5,331  
   

 

 

 
Retail — 15.3%            

BJ’s Restaurants Inc.

    19       754  

Casey’s General Stores Inc.

    33       5,343  

Cheesecake Factory Inc. (The)

    42       1,809  

Chipotle Mexican Grill Inc.(a)

    53       42,163  

Costco Wholesale Corp.

    263       72,491  

Cracker Barrel Old Country Store Inc.

    15       2,606  

Darden Restaurants Inc.

    105       12,764  

Dunkin’ Brands Group Inc.

    117       9,379  

Freshpet Inc.(a)

    53       2,393  

Jack in the Box Inc.

    27       1,939  

McDonald’s Corp.

    931       196,180  
Security   Shares     Value  
Retail (continued)            

Shake Shack Inc., Class A(a)

    31     $ 2,314  

Starbucks Corp.

    2,156       204,152  

Texas Roadhouse Inc.

    42       2,320  

Walmart Inc.

    58       6,402  

Wendy’s Co. (The)

    90       1,637  

Wingstop Inc.

    27       2,581  

Yum China Holdings Inc.

    409       18,609  

Yum! Brands Inc.

    434       48,834  
   

 

 

 
      634,670  
Toys, Games & Hobbies — 0.1%            

Mattel Inc.(a)

    357       5,212  
   

 

 

 

Total Common Stocks — 99.4%
(Cost: $3,686,590)

      4,113,518  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 1.2%            

BlackRock Cash Funds: Institutional,
SL Agency Shares,

   

2.45%(c)(d)(e)

    28,007       28,021  

BlackRock Cash Funds: Treasury,
SL Agency Shares,

   

2.25%(c)(d)

    19,000       19,000  
   

 

 

 
      47,021  
   

 

 

 

Total Short-Term Investments — 1.2%
(Cost: $47,021)

      47,021  
   

 

 

 

Total Investments in Securities — 100.6%
(Cost: $3,733,611)

      4,160,539  

Other Assets, Less Liabilities — (0.6)%

      (23,401
   

 

 

 

Net Assets — 100.0%

    $     4,137,138  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

 

 

Affiliated Issuer

    

Shares
Held at
07/31/18
 
 
 
     Net Activity       

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income       

Net Realized

Gain (Loss

 

)(a) 

    

Change in

Unrealized

Appreciation

(Depreciation

 

 

 

 

 

BlackRock Cash Funds: Institutional,
SL Agency Shares

     10,250        17,757        28,007      $ 28,021      $ 35 (b)     $ (6    $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     200,121        (181,121      19,000        19,000        1,118                
           

 

 

    

 

 

    

 

 

    

 

 

 
            $ 47,021      $ 1,153      $ (6    $  
           

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

 
  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

20    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Consumer Staples ETF

 

Fair Value Measurements (continued)

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 4,113,518        $        $        $ 4,113,518  

Money Market Funds

     47,021                            47,021  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 4,160,539        $         —        $         —        $ 4,160,539  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS      21  


Schedule of Investments  

July 31, 2019

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   
Airlines — 0.2%            

Alaska Air Group Inc.

    104     $   6,589  

JetBlue Airways Corp.(a)

    276       5,308  
   

 

 

 
          11,897  
Apparel — 7.6%            

Capri Holdings Ltd.(a)

    333       11,851  

Carter’s Inc.

    140       13,023  

Columbia Sportswear Co.

    72       7,631  

Crocs Inc.(a)

    136       3,108  

Deckers Outdoor Corp.(a)

    84       13,127  

Hanesbrands Inc.

    736       11,842  

Kontoor Brands Inc.(a)

    94       2,757  

NIKE Inc., Class B

    2,607       224,280  

Oxford Industries Inc.

    48       3,513  

PVH Corp.

    204       18,140  

Ralph Lauren Corp.

    140       14,592  

Skechers U.S.A. Inc., Class A(a)

    336       12,748  

Steven Madden Ltd.

    222       7,661  

Tapestry Inc.

    740       22,888  

Under Armour Inc., Class A(a)

    404       9,320  

Under Armour Inc., Class C, NVS(a)

    412       8,380  

VF Corp.

    663       57,940  

Wolverine World Wide Inc.

    124       3,367  
   

 

 

 
          446,168  
Building Materials — 0.1%            

American Woodmark Corp.(a)

    16       1,358  

Masco Corp.

    104       4,240  
   

 

 

 
          5,598  
Chemicals — 0.1%            

Valvoline Inc.

    168       3,392  
   

 

 

 
Commercial Services — 1.4%            

Aaron’s Inc.

    144       9,080  

Avis Budget Group Inc.(a)

    68       2,475  

Bright Horizons Family Solutions Inc.(a)

    20       3,041  

Brink’s Co. (The)

    36       3,246  

Cintas Corp.

    72       18,752  

Euronet Worldwide Inc.(a)

    40       6,236  

Grand Canyon Education Inc.(a)

    36       3,916  

H&R Block Inc.

    224       6,203  

ManpowerGroup Inc.

    60       5,481  

Medifast Inc.

    12       1,340  

Monro Inc.

    68       5,726  

Rollins Inc.

    120       4,024  

ServiceMaster Global Holdings Inc.(a)(b)

    136       7,239  

Sotheby’s(a)

    36       2,150  

Square Inc., Class A(a)

    67       5,387  

Weight Watchers International Inc.(a)

    36       779  
   

 

 

 
          85,075  
Computers — 4.1%            

Apple Inc.

    1,146       244,144  
   

 

 

 
Cosmetics & Personal Care — 5.9%            

Estee Lauder Companies Inc. (The), Class A

    382       70,360  

Procter & Gamble Co. (The)

    2,369       279,637  
   

 

 

 
          349,997  
Distribution & Wholesale — 1.1%            

Core-Mark Holding Co. Inc.

    58       2,171  

Fastenal Co.

    576       17,741  
Security   Shares      Value  
Distribution & Wholesale (continued)             

Fossil Group Inc.(a)

    100      $   1,104  

G-III Apparel Group Ltd.(a)

    116        3,325  

HD Supply Holdings Inc.(a)

    124        5,023  

IAA Inc.(a)

    96        4,488  

KAR Auction Services Inc.

    96        2,567  

LKQ Corp.(a)

    204        5,494  

Pool Corp.

    44        8,332  

SiteOne Landscape Supply Inc.(a)

    36        2,659  

WW Grainger Inc.

    48        13,969  
    

 

 

 
           66,873  
Diversified Financial Services — 0.1%             

Alliance Data Systems Corp.

    36        5,649  

LendingTree Inc.(a)(b)

    4        1,290  
    

 

 

 
           6,939  
Entertainment — 0.8%             

Cinemark Holdings Inc.

    128        5,110  

Live Nation Entertainment Inc.(a)

    180        12,971  

Madison Square Garden Co. (The), Class A(a)

    20        5,801  

Marriott Vacations Worldwide Corp.

    47        4,805  

Penn National Gaming Inc.(a)

    25        488  

Red Rock Resorts Inc., Class A

    116        2,417  

Scientific Games Corp./DE, Class A(a)

    44        900  

Six Flags Entertainment Corp.

    68        3,592  

Vail Resorts Inc.

    52        12,819  
    

 

 

 
           48,903  
Food — 1.3%             

Flowers Foods Inc.

    180        4,266  

Kroger Co. (The)

    1,873        39,633  

Performance Food Group Co.(a)

    128        5,613  

Sprouts Farmers Market Inc.(a)(b)

    252        4,266  

Sysco Corp.

    210        14,400  

U.S. Foods Holding Corp.(a)

    216        7,640  

United Natural Foods Inc.(a)

    68        670  
    

 

 

 
           76,488  
Food Service — 0.2%             

Aramark

    320        11,581  
    

 

 

 
Home Builders — 0.2%             

PulteGroup Inc.

    172        5,420  

Taylor Morrison Home Corp., Class A(a)

    80        1,801  

Toll Brothers Inc.

    104        3,741  
    

 

 

 
           10,962  
Home Furnishings — 0.1%             

Tempur Sealy International Inc.(a)

    68        5,455  
    

 

 

 
Household Products & Wares — 0.2%             

Helen of Troy Ltd.(a)

    21        3,114  

Kimberly-Clark Corp.

    57        7,732  

Spectrum Brands Holdings Inc.

    16        802  
    

 

 

 
           11,648  
Housewares — 0.1%             

Scotts Miracle-Gro Co. (The)

    32        3,590  

Tupperware Brands Corp.

    44        673  
    

 

 

 
           4,263  
Internet — 16.0%             

Amazon.com Inc.(a)

    408        761,646  

Booking Holdings Inc.(a)

    46        86,784  

Cars.com Inc.(a)

    60        1,140  

eBay Inc.

    493        20,307  
 

 

 

22    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares      Value  
Internet (continued)             

Etsy Inc.(a)

    116      $ 7,774  

Expedia Group Inc.

    75        9,956  

Groupon Inc.(a)

    484        1,525  

GrubHub Inc.(a)

    88        5,951  

MercadoLibre Inc.(a)

    40        24,857  

Shutterfly Inc.(a)(b)

    28        1,419  

Stamps.com Inc.(a)

    12        573  

Stitch Fix Inc., Class A(a)

    54        1,408  

TripAdvisor Inc.(a)

    100        4,415  

Wayfair Inc., Class A(a)

    125        16,395  
    

 

 

 
           944,150  
Leisure Time — 1.2%             

Carnival Corp.

    522        24,654  

Norwegian Cruise Line Holdings Ltd.(a)

    209        10,333  

Planet Fitness Inc., Class A(a)

    208        16,361  

Polaris Industries Inc.

    28        2,651  

Royal Caribbean Cruises Ltd.

    157        18,266  
    

 

 

 
           72,265  
Lodging — 3.0%             

Caesars Entertainment Corp.(a)

    156        1,847  

Choice Hotels International Inc.

    64        5,492  

Extended Stay America Inc.

    172        2,876  

Hilton Grand Vacations Inc.(a)

    84        2,747  

Hilton Worldwide Holdings Inc.

    406        39,199  

Hyatt Hotels Corp., Class A

    64        4,950  

Las Vegas Sands Corp.

    496        29,978  

Marriott International Inc./MD, Class A

    351        48,810  

MGM Resorts International

    572        17,172  

Wyndham Destinations Inc.

    164        7,718  

Wyndham Hotels & Resorts Inc.

    63        3,563  

Wynn Resorts Ltd.

    100        13,007  
    

 

 

 
           177,359  
Office Furnishings — 0.0%             

Herman Miller Inc.

    48        2,176  
    

 

 

 
Oil & Gas — 0.1%             

Murphy USA Inc.(a)

    48        4,241  
    

 

 

 
Pharmaceuticals — 0.1%             

Herbalife Nutrition Ltd.(a)

    94        3,856  
    

 

 

 
Real Estate — 0.0%             

RE/MAX Holdings Inc., Class A

    28        814  

Realogy Holdings Corp.

    100        521  
    

 

 

 
       1,335  
Real Estate Investment Trusts — 0.5%             

Apple Hospitality REIT Inc.

    168        2,639  

CorePoint Lodging Inc.

    78        915  

Host Hotels & Resorts Inc.

    532        9,252  

Macerich Co. (The)

    104        3,437  

Park Hotels & Resorts Inc.

    120        3,169  

Ruth’s Hospitality Group Inc.

    72        1,603  

Ryman Hospitality Properties Inc.

    32        2,400  

Tailored Brands Inc.

    140        682  

Taubman Centers Inc.

    72        2,918  
    

 

 

 
       27,015  
Retail — 54.2%             

Advance Auto Parts Inc.

    158        23,801  

American Eagle Outfitters Inc.

    468        8,279  

Ascena Retail Group Inc.(a)

    514        228  
Security   Shares      Value  
Retail (continued)             

At Home Group Inc.(a)

    117      $ 701  

AutoNation Inc.(a)

    84        4,089  

AutoZone Inc.(a)

    54        60,644  

Beacon Roofing Supply Inc.(a)

    48        1,739  

Bed Bath & Beyond Inc.

    380        3,690  

Best Buy Co. Inc.

    449        34,362  

Big Lots Inc.

    124        3,174  

BJ’s Restaurants Inc.

    36        1,429  

BJ’s Wholesale Club Holdings Inc.(a)

    86        2,026  

Bloomin’ Brands Inc.

    192        3,270  

Boot Barn Holdings Inc.(a)

    85        2,660  

Buckle Inc. (The)

    76        1,547  

Burlington Stores Inc.(a)

    196        35,427  

Caleres Inc.

    100        1,878  

CarMax Inc.(a)(b)

    272        23,871  

Carvana Co.(a)

    46        2,924  

Casey’s General Stores Inc.

    84        13,600  

Cheesecake Factory Inc. (The)

    84        3,619  

Chico’s FAS Inc.

    384        1,225  

Chipotle Mexican Grill Inc.(a)

    41        32,617  

Costco Wholesale Corp.

    965        265,983  

Cracker Barrel Old Country Store Inc.

    56        9,728  

Darden Restaurants Inc.

    268        32,578  

Denny’s Corp.(a)

    144        3,253  

Designer Brands Inc. , Class A

    192        3,529  

Dick’s Sporting Goods Inc.

    208        7,731  

Dillard’s Inc., Class A(b)

    36        2,620  

Dollar General Corp.

    668        89,525  

Dollar Tree Inc.(a)

    639        65,018  

Domino’s Pizza Inc.

    94        22,986  

Dunkin’ Brands Group Inc.

    100        8,016  

Express Inc.(a)

    240        593  

FirstCash Inc.

    76        7,649  

Five Below Inc.(a)

    156        18,324  

Floor & Decor Holdings Inc., Class A(a)(b)

    140        5,481  

Foot Locker Inc.

    256        10,511  

GameStop Corp., Class A(b)

    212        852  

Gap Inc. (The)

    836        16,302  

Genesco Inc.(a)(b)

    56        2,205  

Genuine Parts Co.

    124        12,043  

Guess? Inc.

    140        2,359  

Home Depot Inc. (The)

    2,316        494,906  

Jack in the Box Inc.

    64        4,597  

JC Penney Co. Inc.(a)(b)

    548        436  

Kohl’s Corp.

    488        26,284  

L Brands Inc.

    702        18,217  

La-Z-Boy Inc.

    72        2,375  

Lithia Motors Inc., Class A

    28        3,693  

Lowe’s Companies Inc.

    1,495        151,593  

Lululemon Athletica Inc.(a)

    299        57,136  

Macy’s Inc.

    807        18,343  

McDonald’s Corp.

    1,091        229,895  

MSC Industrial Direct Co. Inc., Class A

    40        2,842  

National Vision Holdings Inc.(a)

    100        3,159  

Nordstrom Inc.

    313        10,363  

Ollie’s Bargain Outlet Holdings Inc.(a)

    124        10,502  

O’Reilly Automotive Inc.(a)

    187        71,202  

PriceSmart Inc.

    56        3,416  

Qurate Retail Inc.(a)

    211        2,984  

Rite Aid Corp.(a)(b)

    90        627  
 

 

 

SCHEDULE OF INVESTMENTS      23  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Discretionary Spending ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Retail (continued)  

Ross Stores Inc.

    1,029     $ 109,105  

Sally Beauty Holdings Inc.(a)

    324       4,452  

Signet Jewelers Ltd.

    143       2,594  

Starbucks Corp.

    1,511       143,077  

Target Corp.

    1,376       118,886  

Texas Roadhouse Inc.

    144       7,953  

Tiffany & Co.

    256       24,043  

TJX Companies Inc. (The)

    3,161       172,464  

Tractor Supply Co.

    332       36,125  

Ulta Salon Cosmetics & Fragrance Inc.(a)

    160       55,880  

Urban Outfitters Inc.(a)

    200       4,762  

Walgreens Boots Alliance Inc.

    1,033       56,288  

Walmart Inc.

    3,294       363,592  

Wendy’s Co. (The)

    340       6,185  

Williams-Sonoma Inc.

    228       15,203  

Wingstop Inc.

    48       4,588  

Yum China Holdings Inc.

    664       30,212  

Yum! Brands Inc.

    627       70,550  
   

 

 

 
      3,192,615  
Software — 0.1%  

Electronic Arts Inc.(a)

    48       4,440  
   

 

 

 
Textiles — 0.0%  

UniFirst Corp./MA

    16       3,150  
   

 

 

 
Toys, Games & Hobbies — 0.2%  

Hasbro Inc.

    96       11,631  
   

 

 

 
Security   Shares     Value  
Transportation — 0.5%  

FedEx Corp.

    168     $ 28,649  
   

 

 

 

Total Common Stocks — 99.4%
(Cost: $4,947,805)

 

    5,862,265  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 1.0%  

BlackRock Cash Funds: Institutional, SL Agency Shares, 2.45%(c)(d)(e)

    27,814       27,828  

BlackRock Cash Funds: Treasury, SL Agency Shares, 2.25%(c)(d) .

    29,000       29,000  
   

 

 

 
      56,828  
   

 

 

 

Total Short-Term Investments — 1.0%
(Cost: $56,825)

 

    56,828  
   

 

 

 

Total Investments in Securities — 100.4%
(Cost: $5,004,630)

 

    5,919,093  

Other Assets, Less Liabilities — (0.4)%

 

    (24,095
   

 

 

 

Net Assets — 100.0%

 

  $   5,894,998  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

 

 
Affiliated Issuer     

Shares
Held at
07/31/18
 
 
 
     Net Activity       

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income       
Net Realized
Gain (Loss)
 
(a) 
    


Change in
Unrealized
Appreciation

(Depreciation)

 
 
 

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

     29,994        (2,180      27,814      $ 27,828      $ 296 (b)     $ 32      $  

BlackRock Cash Funds: Treasury, SL Agency Shares

     28,996        4        29,000        29,000        695                
           

 

 

    

 

 

    

 

 

    

 

 

 
            $ 56,828      $ 991      $ 32      $  
           

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 5,862,265        $             —        $             —        $ 5,862,265  

Money Market Funds

     56,828                            56,828  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 5,919,093        $        $        $ 5,919,093  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

24    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments

July 31, 2019

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Banks — 44.1%  

Ameris Bancorp.

    64     $ 2,545  

Associated Banc-Corp.

    347       7,520  

Atlantic Union Bankshares Corp.

    140       5,324  

BancFirst Corp.

    46       2,684  

Bank of America Corp.

    7,387       226,633  

Bank of Hawaii Corp.

    94       8,014  

Bank of New York Mellon Corp. (The)

    1,290       60,527  

BankUnited Inc.

    216       7,433  

Banner Corp.

    52       3,082  

BB&T Corp.

    1,372       70,699  

BOK Financial Corp.

    53       4,435  

Bryn Mawr Bank Corp.

    63       2,336  

Cadence BanCorp.

    122       2,091  

Cathay General Bancorp.

    180       6,700  

CenterState Bank Corp.

    173       4,207  

Citigroup Inc.

    2,934       208,783  

Citizens Financial Group Inc.

    874       32,565  

City Holding Co.

    40       3,098  

Columbia Banking System Inc.

    153       5,770  

Comerica Inc.

    314       22,985  

Commerce Bancshares Inc.

    200       12,166  

Community Bank System Inc.

    114       7,523  

ConnectOne Bancorp. Inc.

    76       1,737  

Cullen/Frost Bankers Inc.

    118       11,203  

CVB Financial Corp.

    244       5,370  

Eagle Bancorp. Inc.

    67       2,701  

East West Bancorp. Inc.

    288       13,827  

Enterprise Financial Services Corp.

    58       2,417  

Fifth Third Bancorp.

    1,501       44,565  

First BanCorp./Puerto Rico

    384       4,132  

First Bancorp./Southern Pines NC

    71       2,623  

First Busey Corp.

    112       3,027  

First Citizens BancShares Inc./NC, Class A

    15       7,005  

First Commonwealth Financial Corp.

    268       3,690  

First Financial Bancorp.

    210       5,353  

First Financial Bankshares Inc.

    284       9,301  

First Hawaiian Inc.

    121       3,238  

First Horizon National Corp.

    652       10,693  

First Interstate BancSystem Inc., Class A

    83       3,322  

First Midwest Bancorp. Inc.

    230       4,975  

FNB Corp.

    695       8,375  

Fulton Financial Corp.

    382       6,494  

Glacier Bancorp. Inc.

    173       7,250  

Goldman Sachs Group Inc. (The)

    522       114,908  

Great Western Bancorp. Inc.

    127       4,295  

Hancock Whitney Corp.

    169       7,017  

Hanmi Financial Corp.

    78       1,676  

Heartland Financial USA Inc.

    71       3,414  

Heritage Financial Corp./WA

    75       2,139  

Hilltop Holdings Inc.

    160       3,629  

Home BancShares Inc./AR

    318       6,255  

Hope Bancorp Inc.

    282       4,160  

Huntington Bancshares Inc./OH

    1,901       27,089  

IBERIABANK Corp.

    112       8,800  

Independent Bank Corp.

    58       4,510  

Independent Bank Group Inc.

    43       2,443  

International Bancshares Corp.

    134       5,042  

JPMorgan Chase & Co.

    1,950       226,200  
Security   Shares     Value  
Banks (continued)  

KeyCorp

    1,940     $ 35,638  

Lakeland Bancorp. Inc.

    132       2,162  

Lakeland Financial Corp.

    67       3,081  

LegacyTexas Financial Group Inc.

    91       3,889  

M&T Bank Corp.

    119       19,546  

Morgan Stanley

    2,004       89,298  

National Bank Holdings Corp., Class A

    71       2,576  

NBT Bancorp. Inc.

    113       4,373  

Northern Trust Corp.

    386       37,828  

Old National Bancorp./IN

    329       5,794  

PacWest Bancorp.

    229       8,846  

Park National Corp.

    33       3,121  

Pinnacle Financial Partners Inc.

    147       8,929  

Popular Inc.

    194       11,167  

Prosperity Bancshares Inc.

    143       9,923  

Regions Financial Corp.

    2,052       32,688  

Renasant Corp.

    114       4,091  

S&T Bancorp. Inc.

    84       3,198  

Sandy Spring Bancorp. Inc.

    78       2,842  

Seacoast Banking Corp. of Florida(a)

    99       2,677  

ServisFirst Bancshares Inc.

    94       3,202  

Simmons First National Corp., Class A

    177       4,558  

South State Corp.

    82       6,566  

Southside Bancshares Inc.

    85       2,943  

State Street Corp.

    623       36,190  

SunTrust Banks Inc.

    845       56,277  

SVB Financial Group(a)

    95       22,037  

Synovus Financial Corp.

    324       12,367  

TCF Financial Corp.

    260       5,559  

TCF Financial Corp., New

    147       6,180  

Texas Capital Bancshares Inc.(a)

    54       3,398  

Tompkins Financial Corp.

    38       3,115  

U.S. Bancorp.

    2,619       149,676  

UMB Financial Corp.

    94       6,416  

Umpqua Holdings Corp.

    398       6,949  

United Community Banks Inc./GA

    128       3,674  

Valley National Bancorp.

    594       6,629  

Webster Financial Corp.

    186       9,486  

Wells Fargo & Co.

    4,625       223,896  

WesBanco Inc.

    103       3,768  

Westamerica Bancorp.

    61       3,910  

Western Alliance Bancorp.(a)

    152       7,515  

Wintrust Financial Corp.

    116       8,299  

Zions Bancorp. N.A

    385       17,352  
   

 

 

 
      2,191,624  
Commercial Services — 4.7%  

Automatic Data Processing Inc.

    246       40,964  

CoreLogic Inc.(a)

    64       2,917  

Equifax Inc.

    78       10,849  

Euronet Worldwide Inc.(a)

    25       3,898  

FleetCor Technologies Inc.(a)

    42       11,935  

Global Payments Inc.

    100       16,792  

Green Dot Corp., Class A(a)

    57       2,889  

HealthEquity Inc.(a)

    37       3,033  

Insperity Inc.

    29       3,084  

MarketAxess Holdings Inc.

    33       11,122  

Moody’s Corp.

    154       33,008  

S&P Global Inc.

    155       37,967  

Service Corp. International/U.S

    111       5,122  

Total System Services Inc.

    164       22,258  
 

 

 

SCHEDULE OF INVESTMENTS      25  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Commercial Services (continued)  

Verisk Analytics Inc.

    127     $ 19,269  

WEX Inc.(a)

    37       8,069  
   

 

 

 
      233,176  
Diversified Financial Services — 16.8%  

Affiliated Managers Group Inc.

    61       5,233  

Alliance Data Systems Corp.

    33       5,178  

Ally Financial Inc.

    740       24,353  

American Express Co.

    878       109,197  

Ameriprise Financial Inc.

    210       30,557  

Artisan Partners Asset Management Inc., Class A

    70       2,071  

BGC Partners Inc., Class A

    217       1,196  

Boston Private Financial Holdings Inc.

    128       1,477  

Capital One Financial Corp.

    723       66,820  

Cboe Global Markets Inc.

    101       11,040  

Charles Schwab Corp. (The)

    1,733       74,900  

CME Group Inc.

    230       44,717  

Credit Acceptance Corp.(a)(b)

    20       9,561  

Discover Financial Services

    451       40,473  

E*TRADE Financial Corp.

    435       21,224  

Eaton Vance Corp., NVS

    167       7,431  

Evercore Inc., Class A

    38       3,282  

Federated Investors Inc., Class B

    132       4,587  

Franklin Resources Inc.

    415       13,541  

Interactive Brokers Group Inc., Class A

    71       3,639  

Intercontinental Exchange Inc.

    470       41,294  

Invesco Ltd.

    336       6,448  

Janus Henderson Group PLC

    264       5,298  

Jefferies Financial Group Inc.

    355       7,572  

KKR & Co. Inc., Class A, NVS

    601       16,077  

Legg Mason Inc.

    140       5,272  

LendingTree Inc.(a)

    5       1,613  

LPL Financial Holdings Inc.

    116       9,729  

Mastercard Inc., Class A

    320       87,126  

Meta Financial Group Inc.

    57       1,760  

Moelis & Co., Class A

    41       1,494  

Nasdaq Inc.

    105       10,119  

Navient Corp.

    271       3,835  

OneMain Holdings Inc.

    116       4,808  

Raymond James Financial Inc.

    231       18,635  

Santander Consumer USA Holdings Inc.

    147       3,956  

SEI Investments Co.

    153       9,117  

SLM Corp.

    711       6,477  

Stifel Financial Corp.

    123       7,357  

Synchrony Financial

    829       29,745  

T Rowe Price Group Inc.

    307       34,811  

TD Ameritrade Holding Corp.

    303       15,483  

Visa Inc., Class A

    87       15,486  

Waddell & Reed Financial Inc., Class A

    137       2,398  

Western Union Co. (The)

    326       6,846  
   

 

 

 
      833,233  
Electric — 0.1%  

Hawaiian Electric Industries Inc.

    139       6,227  
   

 

 

 
Forest Products & Paper — 0.1%  

International Paper Co.

    102       4,479  
   

 

 

 
Health Care – Services — 2.4%  

Anthem Inc.

    133       39,183  

Cigna Corp.

    256       43,500  

Molina Healthcare Inc.(a)

    33       4,382  
Security   Shares     Value  
Health Care – Services (continued)  

UnitedHealth Group Inc.

    129     $ 32,122  

WellCare Health Plans Inc.(a)

    8       2,298  
   

 

 

 
      121,485  
Insurance — 25.1%  

Aflac Inc.

    1,206       63,484  

Alleghany Corp.(a)

    21       14,400  

Allstate Corp. (The)

    567       60,896  

American Financial Group Inc./OH

    139       14,231  

American International Group Inc.

    1,525       85,385  

American National Insurance Co.

    22       2,662  

Aon PLC

    181       34,254  

Arch Capital Group Ltd.(a)

    475       18,378  

Arthur J Gallagher & Co.

    250       22,607  

Assurant Inc.

    74       8,389  

Assured Guaranty Ltd.

    85       3,714  

Athene Holding Ltd., Class A(a)

    201       8,213  

AXA Equitable Holdings Inc.

    366       8,228  

Axis Capital Holdings Ltd.

    90       5,730  

Berkshire Hathaway Inc., Class B(a)

    594       122,025  

Brighthouse Financial Inc.(a)

    154       6,032  

Brown & Brown Inc.

    331       11,893  

Cincinnati Financial Corp.

    297       31,877  

CNA Financial Corp.

    66       3,161  

Employers Holdings Inc.

    56       2,458  

Erie Indemnity Co., Class A, NVS

    33       7,351  

Essent Group Ltd.(a)

    131       6,047  

Everest Re Group Ltd.

    53       13,072  

Fidelity National Financial Inc.

    344       14,751  

Genworth Financial Inc., Class A(a)

    837       3,340  

Hanover Insurance Group Inc. (The)

    81       10,506  

Hartford Financial Services Group Inc. (The)

    674       38,843  

Horace Mann Educators Corp.

    85       3,692  

Kemper Corp.

    83       7,306  

Lincoln National Corp.

    393       25,679  

Loews Corp.

    240       12,850  

Markel Corp.(a)

    19       21,165  

Marsh & McLennan Companies Inc.

    629       62,145  

Mercury General Corp.

    60       3,403  

MetLife Inc.

    1,389       68,644  

MGIC Investment Corp.(a)

    653       8,391  

National General Holdings Corp.

    118       2,918  

NMI Holdings Inc., Class A(a)

    119       2,961  

Old Republic International Corp.

    379       8,645  

Primerica Inc.

    56       6,871  

Principal Financial Group Inc.

    503       29,194  

ProAssurance Corp.

    105       4,104  

Progressive Corp. (The)

    981       79,441  

Prudential Financial Inc.

    760       76,996  

Radian Group Inc.

    374       8,527  

RenaissanceRe Holdings Ltd.

    61       11,050  

RLI Corp.

    90       8,112  

Safety Insurance Group Inc.

    33       3,256  

Selective Insurance Group Inc.

    112       8,422  

Torchmark Corp.

    220       20,090  

Travelers Companies Inc. (The)

    470       68,911  

Universal Insurance Holdings Inc.

    64       1,588  

Unum Group

    424       13,547  

Voya Financial Inc.

    307       17,244  

Willis Towers Watson PLC

    116       22,646  
 

 

 

26    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Financials ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Insurance (continued)            

WR Berkley Corp.

    283     $ 19,637  
   

 

 

 
      1,249,362  
Machinery — 0.7%            

Caterpillar Inc.

    265       34,893  
   

 

 

 
Media — 0.1%            

FactSet Research Systems Inc.

    16       4,437  
   

 

 

 
Pharmaceuticals — 0.4%            

CVS Health Corp.

    342       19,108  
   

 

 

 
Real Estate — 0.0%            

Realogy Holdings Corp.

    87       453  
   

 

 

 
Real Estate Investment Trusts — 0.7%            

AGNC Investment Corp.

    213       3,651  

Annaly Capital Management Inc.

    930       8,881  

Colony Capital Inc.

    415       2,345  

MFA Financial Inc.

    382       2,743  

New Residential Investment Corp.

    268       4,205  

Two Harbors Investment Corp.

    150       2,019  

Weyerhaeuser Co.

    492       12,501  
   

 

 

 
      36,345  
Retail — 0.1%            

FirstCash Inc.

    30       3,019  
   

 

 

 
Savings & Loans — 1.5%            

Axos Financial Inc.(a)

    95       2,784  

Berkshire Hills Bancorp. Inc.

    75       2,460  

Brookline Bancorp. Inc.

    175       2,595  

Capitol Federal Financial Inc.

    292       3,989  

Investors Bancorp. Inc.

    501       5,691  

Meridian Bancorp. Inc.

    113       2,072  

New York Community Bancorp. Inc.

    937       10,804  

Northwest Bancshares Inc.

    224       3,842  

OceanFirst Financial Corp.

    97       2,367  

Pacific Premier Bancorp. Inc.

    95       3,005  

People’s United Financial Inc.

    759       12,463  

Provident Financial Services Inc.

    140       3,385  

Sterling Bancorp./DE

    450       9,832  
Security   Shares     Value  
Savings & Loans (continued)            

Washington Federal Inc.

    174     $ 6,365  

WSFS Financial Corp.

    118       5,000  
   

 

 

 
          76,654  
Software — 2.6%            

Black Knight Inc.(a)

    48       3,039  

Broadridge Financial Solutions Inc.

    90       11,441  

Fidelity National Information Services Inc.

    457       60,870  

Fiserv Inc.(a)

    277       29,204  

MSCI Inc.

    47       10,680  

Paychex Inc.

    91       7,558  

SS&C Technologies Holdings Inc.

    91       4,363  
   

 

 

 
          127,155  
   

 

 

 

Total Common Stocks — 99.4%
(Cost: $4,873,323)

      4,941,650  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 0.5%            

BlackRock Cash Funds: Institutional,
SL Agency Shares, 2.45%(c)(d)(e)

    1,489       1,490  

BlackRock Cash Funds: Treasury,
SL Agency Shares, 2.25%(c)(d)

    24,000       24,000  
   

 

 

 
          25,490  
   

 

 

 

Total Short-Term Investments — 0.5%
(Cost: $25,490)

 

    25,490  
   

 

 

 

Total Investments in Securities — 99.9%
(Cost: $4,898,813)

 

    4,967,140  

Other Assets, Less Liabilities — 0.1%

 

    4,035  
   

 

 

 

Net Assets — 100.0%

 

  $ 4,971,175  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

Affiliated Issuer     

Shares
Held at
07/31/18
 
 
 
     Net Activity       

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income       
Net Realized
Gain (Loss)
 
(a) 
    


Change in
Unrealized
Appreciation

(Depreciation)

 
 
 

 

BlackRock Cash Funds: Institutional,
SL Agency Shares

            1,489        1,489      $ 1,490      $ 5 (b)     $      $  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     39,373        (15,373      24,000        24,000        804                
           

 

 

    

 

 

    

 

 

    

 

 

 
            $ 25,490      $ 809      $      $  
           

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

 
  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

SCHEDULE OF INVESTMENTS      27  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Financials ETF

 

Fair Value Measurements (continued)

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 4,941,650        $        $        $ 4,941,650  

Money Market Funds

     25,490                            25,490  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 4,967,140        $             —        $             —        $ 4,967,140  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

28    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments

July 31, 2019

  

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Aerospace & Defense — 0.9%  

Lockheed Martin Corp.

    50     $ 18,109  

Northrop Grumman Corp.

    95       32,829  

Raytheon Co.

    65       11,849  
   

 

 

 
      62,787  
Biotechnology — 3.2%            

Bio-Rad Laboratories Inc., Class A(a)

    60       18,894  

Exact Sciences Corp.(a)

    389       44,778  

Guardant Health Inc.(a)

    50       4,699  

Illumina Inc.(a)(b)

    521       155,977  

Myriad Genetics Inc.(a)

    240       6,994  

NeoGenomics Inc.(a)

    300       7,311  
   

 

 

 
      238,653  
Commercial Services — 1.1%            

2U Inc.(a)(b)

    70       896  

Adtalem Global Education Inc.(a)

    145       6,869  

AMN Healthcare Services Inc.(a)

    165       8,808  

ASGN Inc.(a)

    40       2,522  

Bright Horizons Family Solutions Inc.(a)

    80       12,166  

Career Education Corp.(a)

    145       2,749  

Graham Holdings Co., Class B

    10       7,427  

Grand Canyon Education Inc.(a)

    95       10,333  

Healthcare Services Group Inc.

    220       5,260  

HealthEquity Inc.(a)

    70       5,739  

HMS Holdings Corp.(a)

    325       11,342  

Insperity Inc.

    50       5,317  

Strategic Education Inc.

    25       4,450  
   

 

 

 
      83,878  
Computers — 0.4%            

Conduent Inc.(a)

    300       2,730  

Leidos Holdings Inc.

    170       13,957  

MAXIMUS Inc.

    175       12,864  
   

 

 

 
      29,551  
Diversified Financial Services — 0.0%            

WageWorks Inc.(a)

    65       3,326  
   

 

 

 
Electrical Components & Equipment — 0.1%            

Novanta Inc.(a)

    55       4,625  
   

 

 

 
Electronics — 1.3%            

Agilent Technologies Inc.

    671       46,574  

OSI Systems Inc.(a)

    45       5,065  

PerkinElmer Inc.

    260       22,391  

Waters Corp.(a)

    120       25,268  
   

 

 

 
      99,298  
Engineering & Construction — 0.1%            

AECOM(a)

    105       3,775  
   

 

 

 
Environmental Control — 0.1%            

Stericycle Inc.(a)

    120       5,515  
   

 

 

 
Health Care – Products — 47.3%            

Abbott Laboratories

    5,611       488,718  

Abiomed Inc.(a)

    155       43,177  

Accelerate Diagnostics Inc.(a)(b)

    120       2,242  

Align Technology Inc.(a)

    135       28,226  

AngioDynamics Inc.(a)

    120       2,446  

AtriCure Inc.(a)

    120       3,850  

Atrion Corp.

    5       3,848  
Security   Shares     Value  
Health Care – Products (continued)            

Avanos Medical Inc.(a)

    100     $ 4,072  

Axogen Inc.(a)

    55       989  

Baxter International Inc.

    940       78,932  

Becton Dickinson and Co.

    920       232,576  

Bio-Techne Corp.

    70       14,710  

BioTelemetry Inc.(a)

    115       5,399  

Boston Scientific Corp.(a)

    5,161       219,136  

Bruker Corp.

    190       9,092  

Cantel Medical Corp.

    60       5,537  

Cardiovascular Systems Inc.(a)

    105       4,812  

Cooper Companies Inc. (The)

    175       59,045  

Cutera Inc.(a)

    35       895  

Danaher Corp.

    1,621       227,750  

Dentsply Sirona Inc.

    465       25,319  

Edwards Lifesciences Corp.(a)

    820       174,537  

Genomic Health Inc.(a)

    60       4,378  

Globus Medical Inc., Class A(a)

    210       9,572  

Haemonetics Corp.(a)

    120       14,650  

Henry Schein Inc.(a)(b)

    500       33,270  

Hill-Rom Holdings Inc.

    200       21,328  

Hologic Inc.(a)

    820       42,025  

ICU Medical Inc.(a)(b)

    50       12,722  

IDEXX Laboratories Inc.(a)

    205       57,820  

Inogen Inc.(a)

    65       3,998  

Insulet Corp.(a)

    165       20,285  

Integer Holdings Corp.(a)

    75       6,565  

Integra LifeSciences Holdings Corp.(a)

    210       13,312  

Intersect ENT Inc.(a)

    55       1,087  

Intuitive Surgical Inc.(a)

    458       237,936  

iRhythm Technologies Inc.(a)

    70       5,820  

LeMaitre Vascular Inc.

    55       1,820  

LivaNova PLC(a)

    181       13,946  

Luminex Corp.

    115       2,499  

Masimo Corp.(a)

    185       29,202  

Medtronic PLC

    5,080       517,855  

Merit Medical Systems Inc.(a)

    170       6,708  

Natus Medical Inc.(a)

    105       3,262  

Nevro Corp.(a)

    80       5,349  

Novocure Ltd.(a)

    125       10,402  

NuVasive Inc.(a)

    180       11,988  

OraSure Technologies Inc.(a)

    195       1,628  

Patterson Companies Inc.

    250       4,950  

Penumbra Inc.(a)(b)

    105       17,598  

Quidel Corp.(a)

    100       5,903  

ResMed Inc.

    510       65,637  

STAAR Surgical Co.(a)

    134       3,928  

Stryker Corp.

    1,115       233,905  

Tandem Diabetes Care Inc.(a)(b)

    124       7,865  

Teleflex Inc.

    145       49,262  

Thermo Fisher Scientific Inc.

    874       242,692  

Varex Imaging Corp.(a)

    85       2,702  

Varian Medical Systems Inc.(a)

    230       26,995  

Wright Medical Group NV(a)(b)

    290       8,369  

Zimmer Biomet Holdings Inc.

    655       88,510  
   

 

 

 
      3,483,051  
Health Care – Services — 29.2%            

Acadia Healthcare Co. Inc.(a)

    320       10,221  

Amedisys Inc.(a)

    150       20,684  

Anthem Inc.

    840       247,472  

Brookdale Senior Living Inc.(a)

    595       4,635  
 

 

 

SCHEDULE OF INVESTMENTS      29  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Health Care – Services (continued)            

Centene Corp.(a)

    1,430     $ 74,489  

Charles River Laboratories International Inc.(a)

    45       6,054  

Chemed Corp.

    50       20,270  

Cigna Corp.

    981       166,692  

Community Health Systems Inc.(a)

    485       994  

Covetrus Inc.(a)

    200       4,734  

DaVita Inc.(a)

    574       34,354  

Encompass Health Corp.

    485       30,962  

Ensign Group Inc. (The)

    230       13,860  

HCA Healthcare Inc.

    1,103       147,262  

Humana Inc.

    580       172,115  

Invitae Corp.(a)

    246       6,615  

IQVIA Holdings Inc.(a)

    300       47,751  

Laboratory Corp. of America Holdings(a)

    364       60,977  

LHC Group Inc.(a)

    144       18,228  

MEDNAX Inc.(a)

    465       11,425  

Molina Healthcare Inc.(a)

    105       13,942  

National HealthCare Corp.

    40       3,504  

Providence Service Corp. (The)(a)

    50       2,787  

Quest Diagnostics Inc.

    531       54,204  

Select Medical Holdings Corp.(a)

    560       9,374  

Syneos Health Inc.(a)

    60       3,065  

Teladoc Health Inc.(a)

    160       10,918  

Tenet Healthcare Corp.(a)

    445       10,489  

Tivity Health Inc.(a)

    185       3,228  

U.S. Physical Therapy Inc.

    60       7,745  

UnitedHealth Group Inc.

    3,295       820,488  

Universal Health Services Inc., Class B

    371       55,969  

WellCare Health Plans Inc.(a)

    189       54,290  
   

 

 

 
      2,149,797  
Internet — 0.0%            

HealthStream Inc.(a)

    85       2,401  
   

 

 

 
Pharmaceuticals — 10.8%            

AbbVie Inc.

    454       30,245  

Akorn Inc.(a)

    125       465  

Allergan PLC

    421       67,570  

AmerisourceBergen Corp.

    440       38,346  

Bausch Health Companies Inc.(a)

    90       2,157  

Cardinal Health Inc.

    960       43,901  

CVS Health Corp.

    3,728       208,283  

DexCom Inc.(a)

    248       38,904  

Diplomat Pharmacy Inc.(a)

    230       1,212  

Johnson & Johnson

    1,627       211,868  

McKesson Corp.

    525       72,949  

Owens & Minor Inc.(b)

    170       461  

Pfizer Inc.

    1,690       65,640  

PRA Health Sciences Inc.(a)

    70       6,994  

Premier Inc., Class A(a)

    235       9,106  
   

 

 

 
      798,101  
Security   Shares     Value  
Real Estate Investment Trusts — 2.7%            

CoreCivic Inc.

    230     $ 3,903  

GEO Group Inc. (The)

    260       4,631  

HCP Inc.

    790       25,225  

LTC Properties Inc.

    75       3,457  

Medical Properties Trust Inc.

    1,155       20,212  

National Health Investors Inc.

    100       7,938  

Omega Healthcare Investors Inc.

    335       12,160  

Physicians Realty Trust

    410       7,056  

Sabra Health Care REIT Inc.

    400       8,256  

Ventas Inc.

    685       46,094  

Welltower Inc.

    735       61,093  
   

 

 

 
      200,025  
Retail — 0.9%            

Rite Aid Corp.(a)(b)

    136       948  

Walgreens Boots Alliance Inc.

    1,184       64,516  
   

 

 

 
      65,464  
Software — 1.1%            

Cerner Corp.

    949       67,996  

Evolent Health Inc., Class A(a)

    245       1,671  

Omnicell Inc.(a)

    105       7,897  

Tabula Rasa HealthCare Inc.(a)

    50       3,013  
   

 

 

 
      80,577  
   

 

 

 

Total Common Stocks — 99.2%
(Cost: $6,529,674)

      7,310,824  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 4.1%  

BlackRock Cash Funds: Institutional,
SL Agency Shares, 2.45%(c)(d)(e)

    249,945       250,070  

BlackRock Cash Funds: Treasury,
SL Agency Shares, 2.25%(c)(d)

    50,000       50,000  
   

 

 

 
      300,070  
   

 

 

 

Total Short-Term Investments — 4.1%
(Cost: $300,064)

 

    300,070  
   

 

 

 

Total Investments in Securities — 103.3%
(Cost: $6,829,738)

 

    7,610,894  

Other Assets, Less Liabilities — (3.3)%

 

    (246,369
   

 

 

 

Net Assets — 100.0%

 

  $ 7,364,525  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

 

30    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Healthcare Staples ETF

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

 

 
Affiliated Issuer     

Shares
Held at
07/31/18
 
 
 
     Net Activity       

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income       
Net Realized
Gain (Loss)
 
(a) 
    


Change in
Unrealized
Appreciation

(Depreciation)

 
 
 

 

 

 

BlackRock Cash Funds: Institutional,
SL Agency Shares

     4,308        245,637        249,945      $ 250,070      $ 231 (b)     $ 1      $ 5  

BlackRock Cash Funds: Treasury,
SL Agency Shares

     46,420        3,580        50,000        50,000        1,647                
           

 

 

    

 

 

    

 

 

    

 

 

 
            $ 300,070      $ 1,878      $ 1      $ 5  
           

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

 
  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 7,310,824        $        $        $ 7,310,824  

Money Market Funds

     300,070                            300,070  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 7,610,894        $             —        $             —        $ 7,610,894  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS      31  


Schedule of Investments

July 31, 2019

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Biotechnology — 39.3%  

Abeona Therapeutics Inc.(a)

    136     $ 352  

ACADIA Pharmaceuticals Inc.(a)

    412       10,127  

Acceleron Pharma Inc.(a)

    188       8,208  

Achillion Pharmaceuticals Inc.(a)

    624       2,752  

Acorda Therapeutics Inc.(a)(b)

    204       1,414  

Aduro Biotech Inc.(a)

    184       243  

Agenus Inc.(a)

    348       839  

Alder Biopharmaceuticals Inc.(a)(b)

    312       3,157  

Alexion Pharmaceuticals Inc.(a)

    845       95,730  

Allakos Inc.(a)

    74       2,573  

Allogene Therapeutics Inc.(a)

    117       3,627  

Alnylam Pharmaceuticals Inc.(a)

    414       32,122  

AMAG Pharmaceuticals Inc.(a)

    128       1,057  

Amgen Inc.

    1,284       239,569  

Amicus Therapeutics Inc.(a)

    876       10,862  

AnaptysBio Inc.(a)

    68       3,652  

ANI Pharmaceuticals Inc.(a)

    28       2,369  

Apellis Pharmaceuticals Inc.(a)

    135       3,771  

Arena Pharmaceuticals Inc.(a)

    256       16,046  

ArQule Inc.(a)

    498       5,025  

Arrowhead Pharmaceuticals Inc.(a)

    360       10,462  

Assembly Biosciences Inc.(a)

    88       1,100  

Atara Biotherapeutics Inc.(a)(b)

    128       1,827  

Audentes Therapeutics Inc.(a)

    128       4,982  

AVEO Pharmaceuticals Inc.(a)(b)

    536       333  

BioCryst Pharmaceuticals Inc.(a)

    428       1,357  

Biogen Inc.(a)

    726       172,657  

Biohaven Pharmaceutical Holding Co. Ltd.(a)

    83       3,572  

BioMarin Pharmaceutical Inc.(a)

    850       67,422  

Bio-Rad Laboratories Inc., Class A(a)

    8       2,519  

Bluebird Bio Inc.(a)(b)

    191       25,065  

Blueprint Medicines Corp.(a)

    184       18,428  

Cambrex Corp.(a)

    48       2,102  

Cara Therapeutics Inc.(a)

    144       3,447  

Celgene Corp.(a)

    2,438       223,955  

Celldex Therapeutics Inc.(a)

    44       96  

ChemoCentryx Inc.(a)(b)

    132       1,053  

Cymabay Therapeutics Inc.(a)

    319       1,971  

CytomX Therapeutics Inc.(a)

    156       1,608  

Deciphera Pharmaceuticals Inc.(a)(b)

    84       1,856  

Denali Therapeutics Inc.(a)

    344       7,344  

Dicerna Pharmaceuticals Inc.(a)

    192       2,617  

Dynavax Technologies Corp.(a)

    256       707  

Editas Medicine Inc.(a)

    192       4,848  

Emergent BioSolutions Inc.(a)

    128       5,650  

Epizyme Inc.(a)

    240       3,182  

Esperion Therapeutics Inc.(a)(b)

    124       4,922  

Exact Sciences Corp.(a)

    184       21,180  

Exelixis Inc.(a)

    1,288       27,396  

Fate Therapeutics Inc.(a)(b)

    220       4,851  

FibroGen Inc.(a)

    312       14,745  

Five Prime Therapeutics Inc.(a)

    180       920  

Geron Corp.(a)

    492       590  

Gilead Sciences Inc.

    3,230       211,630  

GlycoMimetics Inc.(a)

    185       1,708  

Guardant Health Inc.(a)

    39       3,666  

Halozyme Therapeutics Inc.(a)

    480       8,155  

ImmunoGen Inc.(a)

    758       1,706  
Security   Shares     Value  
Biotechnology (continued)  

Immunomedics Inc.(a)

    804     $ 11,859  

Incyte Corp.(a)

    356       30,232  

Innoviva Inc.(a)

    236       2,804  

Insmed Inc.(a)

    360       7,902  

Intercept Pharmaceuticals Inc.(a)

    88       5,531  

Intrexon Corp.(a)

    176       1,406  

Ionis Pharmaceuticals Inc.(a)

    580       38,199  

Iovance Biotherapeutics Inc.(a)

    396       9,738  

Karyopharm Therapeutics Inc.(a)

    224       1,973  

Lexicon Pharmaceuticals Inc.(a)

    212       286  

Ligand Pharmaceuticals Inc.(a)

    96       8,785  

MacroGenics Inc.(a)

    160       2,302  

Medicines Co. (The)(a)

    312       11,182  

Myriad Genetics Inc.(a)

    140       4,080  

Nektar Therapeutics(a)

    781       22,227  

Novavax Inc.(a)

    64       276  

Omeros Corp.(a)(b)

    188       2,916  

Pieris Pharmaceuticals Inc.(a)

    256       1,408  

PTC Therapeutics Inc.(a)

    202       9,730  

Puma Biotechnology Inc.(a)

    156       1,505  

Radius Health Inc.(a)

    200       4,292  

Regeneron Pharmaceuticals Inc.(a)

    348       106,057  

REGENXBIO Inc.(a)

    136       6,040  

Retrophin Inc.(a)

    188       3,721  

Rigel Pharmaceuticals Inc.(a)

    716       1,632  

Rocket Pharmaceuticals Inc.(a)(b)

    105       1,279  

Sage Therapeutics Inc.(a)

    227       36,397  

Sangamo Therapeutics Inc.(a)

    396       4,756  

Seattle Genetics Inc.(a)

    492       37,249  

Solid Biosciences Inc.(a)

    65       372  

Sorrento Therapeutics Inc.(a)

    276       742  

Spark Therapeutics Inc.(a)

    152       15,203  

Stemline Therapeutics Inc.(a)

    148       1,964  

Theravance Biopharma Inc.(a)

    94       1,960  

Ultragenyx Pharmaceutical Inc.(a)

    224       13,498  

United Therapeutics Corp.(a)

    188       14,897  

Verastem Inc.(a)(b)

    403       605  

Vericel Corp.(a)

    95       1,816  

Vertex Pharmaceuticals Inc.(a)

    1,181       196,778  

Viking Therapeutics Inc.(a)(b)

    258       1,984  

ZIOPHARM Oncology Inc.(a)

    608       4,220  
   

 

 

 
      1,944,927  
Electrical Components & Equipment — 0.2%  

Universal Display Corp.

    56       11,821  
   

 

 

 
Health Care – Products — 5.6%  

Abbott Laboratories

    455       39,631  

Abiomed Inc.(a)

    32       8,914  

Axogen Inc.(a)

    56       1,007  

Baxter International Inc.

    604       50,718  

Bio-Techne Corp.

    44       9,247  

Cooper Companies Inc. (The)

    68       22,943  

Glaukos Corp.(a)(b)

    104       8,495  

Globus Medical Inc., Class A(a)

    84       3,829  

Haemonetics Corp.(a)

    52       6,348  

Hologic Inc.(a)

    144       7,380  

ICU Medical Inc.(a)

    20       5,089  

IDEXX Laboratories Inc.(a)

    66       18,615  

Insulet Corp.(a)(b)

    84       10,327  

Integra LifeSciences Holdings Corp.(a)

    68       4,311  
 

 

 

32    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Health Care – Products (continued)  

Intersect ENT Inc.(a)

    72     $ 1,423  

Intuitive Surgical Inc.(a)

    29       15,066  

Lantheus Holdings Inc.(a)

    112       2,533  

Merit Medical Systems Inc.(a)

    52       2,052  

Nevro Corp.(a)

    56       3,744  

Novocure Ltd.(a)

    152       12,649  

OPKO Health Inc.(a)(b)

    916       1,933  

Penumbra Inc.(a)(b)

    52       8,715  

Quidel Corp.(a)

    40       2,361  

Repligen Corp.(a)

    88       8,306  

ResMed Inc.

    180       23,166  
   

 

 

 
      278,802  
Health Care – Services — 1.2%  

Catalent Inc.(a)

    208       11,750  

Charles River Laboratories International Inc.(a)

    72       9,687  

IQVIA Holdings Inc.(a)

    208       33,107  

Syneos Health Inc.(a)

    112       5,722  
   

 

 

 
      60,266  
Pharmaceuticals — 52.0%  

AbbVie Inc.

    2,800       186,536  

Aclaris Therapeutics Inc.(a)

    136       174  

Adamas Pharmaceuticals Inc.(a)(b)

    92       576  

Aerie Pharmaceuticals Inc.(a)

    180       3,901  

Agios Pharmaceuticals Inc.(a)

    228       10,969  

Aimmune Therapeutics Inc.(a)

    192       3,696  

Akcea Therapeutics Inc.(a)(b)

    52       1,125  

Akebia Therapeutics Inc.(a)

    384       1,609  

Akorn Inc.(a)

    208       774  

Alkermes PLC(a)

    524       12,136  

Allergan PLC

    785       125,992  

AmerisourceBergen Corp.

    56       4,880  

Amneal Pharmaceuticals Inc.(a)

    537       1,965  

Amphastar Pharmaceuticals Inc.(a)

    132       2,660  

Anika Therapeutics Inc.(a)

    40       2,204  

Athenex Inc.(a)

    140       2,520  

Axsome Therapeutics Inc.(a)

    90       2,295  

Bausch Health Companies Inc.(a)(b)

    888       21,285  

Bristol-Myers Squibb Co.

    4,635       205,840  

Catalyst Pharmaceuticals Inc.(a)

    301       1,502  

Clovis Oncology Inc.(a)(b)

    232       2,448  

Coherus Biosciences Inc.(a)

    196       3,297  

Collegium Pharmaceutical Inc.(a)

    108       1,185  

Concert Pharmaceuticals Inc.(a)

    96       966  

Corbus Pharmaceuticals Holdings Inc.(a)(b)

    224       1,344  

Corcept Therapeutics Inc.(a)(b)

    440       4,954  

Cyclerion Therapeutics Inc.(a)

    60       557  

Cytokinetics Inc.(a)

    216       2,633  

Dermira Inc.(a)

    276       2,432  

DexCom Inc.(a)

    135       21,177  

Dova Pharmaceuticals Inc.(a)

    64       1,023  

Eagle Pharmaceuticals Inc./DE(a)

    56       3,072  

Elanco Animal Health Inc.(a)

    510       16,810  

Eli Lilly & Co.

    2,116       230,538  

Enanta Pharmaceuticals Inc.(a)

    68       5,101  

Endo International PLC(a)

    202       640  

Flexion Therapeutics Inc.(a)

    156       1,566  

G1 Therapeutics Inc.(a)(b)

    88       2,183  

Global Blood Therapeutics Inc.(a)

    220       12,056  

Heron Therapeutics Inc.(a)

    328       5,720  
Security   Shares     Value  
Pharmaceuticals (continued)  

Horizon Therapeutics PLC(a)

    576     $ 14,337  

Intellia Therapeutics Inc.(a)

    136       2,462  

Intra-Cellular Therapies Inc.(a)

    208       1,737  

Ironwood Pharmaceuticals Inc.(a)

    600       6,378  

Jazz Pharmaceuticals PLC(a)

    166       23,137  

Johnson & Johnson

    4,154       540,934  

Jounce Therapeutics Inc.(a)

    72       345  

Kura Oncology Inc.(a)

    148       2,830  

La Jolla Pharmaceutical Co.(a)

    92       769  

Lannett Co. Inc.(a)(b)

    116       820  

Madrigal Pharmaceuticals Inc.(a)(b)

    16       1,397  

Mallinckrodt PLC(a)

    174       1,185  

MediciNova Inc.(a)

    164       1,565  

Merck & Co. Inc.

    4,785       397,107  

Mirati Therapeutics Inc.(a)

    155       16,399  

Momenta Pharmaceuticals Inc.(a)

    324       3,661  

Mylan NV(a)

    1,111       23,220  

MyoKardia Inc.(a)

    140       7,620  

Neurocrine Biosciences Inc.(a)

    442       42,604  

Pacira BioScience Inc.(a)

    152       6,671  

Paratek Pharmaceuticals Inc.(a)(b)

    124       401  

Perrigo Co. PLC

    126       6,805  

Pfizer Inc.

    8,828       342,880  

Portola Pharmaceuticals Inc.(a)(b)

    356       9,498  

PRA Health Sciences Inc.(a)

    84       8,392  

Prestige Consumer Healthcare Inc.(a)(b)

    64       2,214  

Progenics Pharmaceuticals Inc.(a)

    308       1,657  

Ra Pharmaceuticals Inc.(a)

    99       3,370  

Reata Pharmaceuticals Inc., Class A(a)(b)

    72       6,527  

Revance Therapeutics Inc.(a)

    144       1,812  

Rhythm Pharmaceuticals Inc.(a)(b)

    80       1,540  

Sarepta Therapeutics Inc.(a)(b)

    310       46,144  

Spectrum Pharmaceuticals Inc.(a)

    468       3,547  

Supernus Pharmaceuticals Inc.(a)(b)

    220       7,341  

Synergy Pharmaceuticals Inc.(a)(b)

    1,136       7  

TG Therapeutics Inc.(a)

    236       1,768  

TherapeuticsMD Inc.(a)(b)

    640       1,376  

Tricida Inc.(a)

    76       2,399  

Vanda Pharmaceuticals Inc.(a)

    224       2,789  

Voyager Therapeutics Inc.(a)

    128       2,817  

Xencor Inc.(a)

    240       10,565  

Zoetis Inc.

    816       93,750  

Zogenix Inc.(a)

    152       7,322  
   

 

 

 
      2,572,440  
Telecommunications — 0.1%  

InterDigital Inc.

    36       2,319  
   

 

 

 

Total Common Stocks — 98.4%
(Cost: $4,923,872)

 

    4,870,575  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 5.3%  

BlackRock Cash Funds: Institutional, SL Agency Shares, 2.45%(c)(d)(e)

    187,167       187,261  
 

 

 

SCHEDULE OF INVESTMENTS      33  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Innovative Healthcare ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Money Market Funds (continued)  

BlackRock Cash Funds: Treasury, SL Agency Shares, 2.25%(c)(d)

    73,000     $ 73,000  
   

 

 

 
      260,261  
   

 

 

 

Total Short-Term Investments — 5.3%
(Cost: $260,217)

 

    260,261  
   

 

 

 

Total Investments in Securities — 103.7%
(Cost: $5,184,089)

 

    5,130,836  

Other Assets, Less Liabilities — (3.7)%

 

    (182,029
   

 

 

 

Net Assets — 100.0%

 

  $   4,948,807  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

 

 
Affiliated Issuer     

Shares
Held at
07/31/18
 
 
 
     Net Activity       

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income       
Net Realized
Gain (Loss)
 
(a) 
    


Change in
Unrealized
Appreciation

(Depreciation)

 
 
 

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

     80,074        107,093        187,167      $ 187,261      $ 2,450 (b)     $ 14      $ 36  

BlackRock Cash Funds: Treasury, SL Agency Shares

     53,493        19,507        73,000        73,000        1,033                
           

 

 

    

 

 

    

 

 

    

 

 

 
            $ 260,261      $ 3,483      $ 14      $ 36  
           

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 4,870,575        $             —        $             —        $ 4,870,575  

Money Market Funds

     260,261                            260,261  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 5,130,836        $        $        $ 5,130,836  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

34    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  

July 31, 2019

  

iShares® Evolved U.S. Media and Entertainment ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Common Stocks  

Advertising — 0.1%

 

National CineMedia Inc.

    1,205     $ 8,580  
   

 

 

 
Commercial Services — 1.9%            

Graham Holdings Co., Class B

    60       44,564  

Nielsen Holdings PLC

    3,520       81,523  

Viad Corp.

    80       5,531  
   

 

 

 
      131,618  
Entertainment — 6.2%            

AMC Entertainment Holdings Inc., Class A

    550       6,506  

Churchill Downs Inc.

    154       18,426  

Cinemark Holdings Inc.

    1,555       62,076  

Eldorado Resorts Inc.(a)

    90       4,061  

IMAX Corp.(a)

    960       21,072  

International Speedway Corp., Class A

    350       15,778  

Lions Gate Entertainment Corp., Class A

    1,595       20,591  

Lions Gate Entertainment Corp., Class B, NVS

    3,209       39,118  

Live Nation Entertainment Inc.(a)

    1,260       90,796  

Madison Square Garden Co. (The), Class A(a)

    240       69,610  

Penn National Gaming Inc.(a)

    160       3,123  

Reading International Inc., Class A, NVS(a)

    225       2,936  

Scientific Games Corp./DE, Class A(a)

    405       8,282  

SeaWorld Entertainment Inc.(a)

    595       18,189  

Six Flags Entertainment Corp.

    935       49,396  

Speedway Motorsports Inc.

    185       3,663  
   

 

 

 
      433,623  
Home Furnishings — 0.7%            

Dolby Laboratories Inc., Class A

    705       48,010  
   

 

 

 
Internet — 14.7%            

Alphabet Inc., Class A(a)

    114       138,875  

Alphabet Inc., Class C, NVS(a)

    113       137,485  

IAC/InterActiveCorp.(a)

    650       155,383  

Netflix Inc.(a)

    900       290,691  

New Media Investment Group Inc.

    590       6,354  

Roku Inc.(a)(b)

    800       82,664  

Snap Inc., Class A, NVS(a)

    869       14,599  

Twitter Inc.(a)

    5,059       214,046  
   

 

 

 
      1,040,097  
Leisure Time — 0.3%            

Carnival Corp.

    326       15,397  

Liberty TripAdvisor Holdings Inc., Class A(a)

    436       5,036  
   

 

 

 
      20,433  
Lodging — 1.0%            

Las Vegas Sands Corp.

    1,096       66,242  

Marcus Corp. (The)

    150       5,249  
   

 

 

 
      71,491  
Media — 59.4%            

Altice USA Inc., Class A(a)

    3,969       102,440  

AMC Networks Inc., Class A(a)

    1,080       57,650  

Cable One Inc.

    60       73,008  

CBS Corp., Class B, NVS

    6,118       315,138  

Central European Media Enterprises Ltd., Class A(a)

    1,111       5,222  

Charter Communications Inc., Class A(a)

    945       364,184  

Comcast Corp., Class A

    10,285       444,003  

Discovery Inc., Class A(a)

    3,440       104,266  

Discovery Inc., Class C, NVS(a)

    8,118       229,252  

DISH Network Corp., Class A(a)

    3,444       116,614  

Entercom Communications Corp., Class A

    3,310       18,801  
Security   Shares      Value  
Media (continued)  

Entravision Communications Corp., Class A

    758      $ 2,471  

EW Scripps Co. (The), Class A, NVS

    1,720        26,368  

Fox Corp., Class A, NVS

    2,033        75,872  

Fox Corp., Class B

    2,032        75,590  

Gannett Co. Inc.

    1,245        12,761  

Gray Television Inc.(a)

    2,360        41,890  

Hemisphere Media Group Inc.(a)

    515        6,340  

Houghton Mifflin Harcourt Co.(a)

    645        3,773  

John Wiley & Sons Inc., Class A

    254        11,560  

Liberty Broadband Corp., Class A(a)

    360        35,348  

Liberty Broadband Corp., Class C, NVS(a)

    1,645        163,694  

Liberty Global PLC, Class A(a)

    1,555        41,472  

Liberty Global PLC, Class C, NVS(a)

    5,038        131,190  

Liberty Latin America Ltd., Class A(a)

    193        3,163  

Liberty Latin America Ltd., Class C, NVS(a)

    913        14,973  

Liberty Media Corp.-Liberty SiriusXM,
Class A(a)

    536        22,314  

Liberty Media Corp.-Liberty SiriusXM,
Class C, NVS(a)

    526        22,018  

Meredith Corp.

    950        52,117  

MSG Networks Inc., Class A(a)

    1,315        24,972  

New York Times Co. (The), Class A

    2,360        84,205  

News Corp., Class A, NVS

    6,919        91,054  

News Corp., Class B

    2,160        29,074  

Nexstar Media Group Inc., Class A

    1,280        130,266  

Saga Communications Inc., Class A

    135        4,215  

Scholastic Corp., NVS

    270        9,226  

Sinclair Broadcast Group Inc., Class A

    1,618        81,305  

Sirius XM Holdings Inc.

    21,555        134,934  

TEGNA Inc.

    5,365        81,494  

Tribune Media Co., Class A

    1,565        72,726  

Viacom Inc., Class A

    275        9,614  

Viacom Inc., Class B, NVS

    9,580        290,753  

Walt Disney Co. (The)

    3,433        490,953  

World Wrestling Entertainment Inc., Class A

    1,139        82,896  
    

 

 

 
       4,191,179  
Real Estate Investment Trusts — 0.8%             

Lamar Advertising Co., Class A

    575        46,529  

Ryman Hospitality Properties Inc.

    105        7,875  
    

 

 

 
       54,404  
Retail — 0.9%             

Qurate Retail Inc.(a)

    4,300        60,802  
    

 

 

 
Software — 9.0%             

Activision Blizzard Inc.

    5,640        274,894  

Daily Journal Corp.(a)

    10        2,481  

Electronic Arts Inc.(a)

    2,239        207,107  

Glu Mobile Inc.(a)

    1,005        7,497  

Take-Two Interactive Software Inc.(a)

    873        106,960  

TiVo Corp.

    1,635        12,393  

Zynga Inc., Class A(a)

    3,825        24,404  
    

 

 

 
       635,736  
Telecommunications — 0.9%             

AT&T Inc.

    1,476        50,258  

Harmonic Inc.(a)(b)

    580        4,333  

Shenandoah Telecommunications Co.

    271        10,666  
    

 

 

 
       65,257  
Toys, Games & Hobbies — 3.4%             

Hasbro Inc.

    1,640        198,702  
 

 

 

SCHEDULE OF INVESTMENTS      35  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Media and Entertainment ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Toys, Games & Hobbies (continued)  

Mattel Inc.(a)

    2,983     $ 43,552  
   

 

 

 
      242,254  
   

 

 

 

Total Common Stocks — 99.3%
(Cost: $6,476,622)

      7,003,484  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 1.9%            

BlackRock Cash Funds: Institutional,
SL Agency Shares, 2.45%(c)(d)(e)

    87,096       87,140  

BlackRock Cash Funds: Treasury,
SL Agency Shares, 2.25%(c)(d)

    51,000       51,000  
   

 

 

 
      138,140  
   

 

 

 

Total Short-Term Investments — 1.9%
(Cost: $138,130)

 

    138,140  
   

 

 

 

Total Investments in Securities — 101.2%
(Cost: $6,614,752)

 

    7,141,624  

Other Assets, Less Liabilities — (1.2)%

 

    (85,798
   

 

 

 

Net Assets — 100.0%

    $ 7,055,826  
   

 

 

 

 

 

(a) 

Non-income producing security.

 
(b) 

All or a portion of this security is on loan.

 
(c) 

Affiliate of the Fund.

 
(d) 

Annualized 7-day yield as of period-end.

 
(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 
 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

 

 

Affiliated Issuer

   

Shares
Held at
07/31/18
 
 
 
     Net Activity      

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income      
Net Realized
Gain (Loss)
 
(a)  
   


Change in
Unrealized
Appreciation
(Depreciation)
 
 
 
 

 

 

BlackRock Cash Funds: Institutional,
SL Agency Shares

    381,922        (294,826     87,096      $ 87,140      $ 1,468 (b)    $ 12     $ (28

BlackRock Cash Funds: Treasury,
SL Agency Shares

    178,979        (127,979     51,000        51,000        2,313              
         

 

 

    

 

 

   

 

 

   

 

 

 
          $ 138,140      $ 3,781     $ 12     $ (28
         

 

 

    

 

 

   

 

 

   

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

 
  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 7,003,484        $        $        $ 7,003,484  

Money Market Funds

     138,140                            138,140  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 7,141,624        $         —        $         —        $ 7,141,624  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

36    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  

July 31, 2019

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Common Stocks  

Advertising — 0.3%

 

Omnicom Group Inc.

    319     $ 25,590  

Trade Desk Inc. (The), Class A(a)(b)

    55       14,482  
   

 

 

 
      40,072  
Aerospace & Defense — 0.1%            

Raytheon Co.

    66       12,031  
   

 

 

 
Banks — 0.4%            

JPMorgan Chase & Co.

    516       59,856  
   

 

 

 
Commercial Services — 4.7%            

2U Inc.(a)

    77       986  

Automatic Data Processing Inc.

    616       102,576  

Booz Allen Hamilton Holding Corp.

    165       11,344  

CoreLogic Inc.(a)(b)

    99       4,511  

CoStar Group Inc.(a)

    44       27,078  

Equifax Inc.

    154       21,420  

Euronet Worldwide Inc.(a)

    55       8,575  

FleetCor Technologies Inc.(a)

    110       31,259  

Gartner Inc.(a)(b)

    176       24,522  

Global Payments Inc.

    209       35,095  

IHS Markit Ltd.(a)

    496       31,952  

Korn Ferry

    88       3,457  

LiveRamp Holdings Inc.(a)

    52       2,740  

ManpowerGroup Inc.

    77       7,034  

MarketAxess Holdings Inc.

    33       11,122  

Moody’s Corp.

    143       30,651  

Nielsen Holdings PLC

    372       8,615  

Paylocity Holding Corp.(a)

    110       11,230  

PayPal Holdings Inc.(a)

    1,771       195,518  

Robert Half International Inc.

    121       7,310  

S&P Global Inc.

    264       64,667  

Sabre Corp.

    341       8,017  

Square Inc., Class A(a)(b)

    593       47,683  

Total System Services Inc.

    187       25,380  

TransUnion

    264       21,856  

Verisk Analytics Inc.

    165       25,034  

WEX Inc.(a)

    44       9,595  
   

 

 

 
      779,227  
Computers — 14.6%            

Accenture PLC, Class A

    1,164       224,163  

Apple Inc.

    6,850       1,459,324  

Cognizant Technology Solutions Corp., Class A

    1,100       71,654  

Conduent Inc.(a)

    275       2,503  

Dell Technologies Inc., Class C(a)

    276       15,936  

DXC Technology Co.

    616       34,354  

Elastic NV(a)

    100       9,883  

EPAM Systems Inc.(a)

    88       17,054  

Fortinet Inc.(a)

    352       28,269  

Genpact Ltd.

    253       10,039  

Hewlett Packard Enterprise Co.

    3,245       46,631  

HP Inc.

    2,134       44,899  

International Business Machines Corp.

    2,186       324,053  

Lumentum Holdings Inc.(a)

    66       3,738  

NCR Corp.(a)

    176       5,951  

NetApp Inc.

    660       38,603  

NetScout Systems Inc.(a)(b)

    187       4,869  

Nutanix Inc., Class A(a)

    242       5,493  

Pure Storage Inc., Class A(a)(b)

    242       3,664  
Security   Shares     Value  
Computers (continued)  

Qualys Inc.(a)(b)

    88     $ 7,617  

Seagate Technology PLC

    396       18,339  

Western Digital Corp.

    528       28,454  
   

 

 

 
      2,405,490  
Distribution & Wholesale — 0.1%            

Copart Inc.(a)

    132       10,234  

IAA Inc.(a)

    99       4,628  

KAR Auction Services Inc.

    99       2,647  
   

 

 

 
      17,509  
Diversified Financial Services — 6.6%            

Alliance Data Systems Corp.

    55       8,631  

Cboe Global Markets Inc.

    110       12,024  

CME Group Inc.

    330       64,158  

Deluxe Corp.

    77       3,436  

Discover Financial Services

    88       7,897  

Interactive Brokers Group Inc., Class A

    66       3,383  

Intercontinental Exchange Inc.

    638       56,055  

Invesco Ltd.

    244       4,682  

Mastercard Inc., Class A

    1,388       377,911  

Nasdaq Inc.

    121       11,661  

SEI Investments Co.

    132       7,866  

TD Ameritrade Holding Corp.

    231       11,804  

Visa Inc., Class A

    2,893       514,954  

Western Union Co. (The)

    429       9,009  
   

 

 

 
      1,093,471  
Electronics — 0.5%            

Arrow Electronics Inc.(a)

    88       6,390  

Avnet Inc.

    165       7,494  

Coherent Inc.(a)

    22       3,055  

Garmin Ltd.

    100       7,859  

Jabil Inc.

    165       5,095  

Keysight Technologies Inc.(a)

    231       20,679  

National Instruments Corp.

    209       8,728  

SYNNEX Corp.

    44       4,336  

Tech Data Corp.(a)

    66       6,688  

Trimble Inc.(a)

    286       12,086  
   

 

 

 
      82,410  
Health Care - Products — 0.1%            

Align Technology Inc.(a)

    74       15,472  
   

 

 

 
Health Care - Services — 0.1%            

IQVIA Holdings Inc.(a)

    121       19,260  
   

 

 

 
Insurance — 0.5%            

Aon PLC

    186       35,200  

Marsh & McLennan Companies Inc.

    297       29,344  

Willis Towers Watson PLC

    103       20,108  
   

 

 

 
      84,652  
Internet — 26.2%            

Alphabet Inc., Class A(a)

    602       733,356  

Alphabet Inc., Class C, NVS(a)

    613       745,825  

Amazon.com Inc.(a)

    629       1,174,205  

Anaplan Inc.(a)

    316       17,993  

Booking Holdings Inc.(a)

    54       101,877  

CDW Corp./DE

    242       28,595  

eBay Inc.

    1,693       69,735  

Etsy Inc.(a)

    109       7,305  

Expedia Group Inc.

    143       18,982  

F5 Networks Inc.(a)

    143       20,981  
 

 

 

SCHEDULE OF INVESTMENTS      37  


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Internet (continued)  

Facebook Inc., Class A(a)

    4,818     $ 935,800  

FireEye Inc.(a)

    341       5,115  

GoDaddy Inc., Class A(a)

    253       18,565  

GrubHub Inc.(a)

    99       6,695  

IAC/InterActiveCorp.(a)

    99       23,666  

MercadoLibre Inc.(a)

    66       41,014  

Netflix Inc.(a)

    297       95,928  

Okta Inc.(a)

    187       24,465  

Palo Alto Networks Inc.(a)

    220       49,839  

Proofpoint Inc.(a)

    121       15,270  

RingCentral Inc., Class A(a)

    121       17,179  

Roku Inc.(a)(b)

    142       14,673  

Snap Inc., Class A, NVS(a)

    737       12,381  

Stamps.com Inc.(a)

    33       1,576  

Symantec Corp.

    1,089       23,479  

Twitter Inc.(a)

    1,266       53,564  

VeriSign Inc.(a)

    154       32,508  

Yelp Inc.(a)

    132       4,627  

Zendesk Inc.(a)

    187       15,626  

Zillow Group Inc., Class C, NVS(a)

    154       7,694  
   

 

 

 
      4,318,518  
Machinery — 0.1%            

Cognex Corp.

    220       9,682  

Rockwell Automation Inc.

    44       7,075  
   

 

 

 
      16,757  
Media — 0.1%            

FactSet Research Systems Inc.

    55       15,251  
   

 

 

 
Office & Business Equipment — 0.1%            

Zebra Technologies Corp., Class A(a)

    88       18,558  
   

 

 

 
Real Estate — 0.0%            

Jones Lang LaSalle Inc.

    44       6,410  
   

 

 

 
Real Estate Investment Trusts — 0.4%            

Digital Realty Trust Inc.

    206       23,558  

Equinix Inc.

    78       39,164  

Iron Mountain Inc.

    297       8,735  
   

 

 

 
      71,457  
Retail — 0.1%            

Best Buy Co. Inc.

    154       11,786  
   

 

 

 
Semiconductors — 8.8%            

Advanced Micro Devices Inc.(a)

    1,694       51,582  

Analog Devices Inc.

    407       47,806  

Applied Materials Inc.

    1,087       53,665  

Broadcom Inc.

    529       153,405  

Cypress Semiconductor Corp.

    594       13,644  

Intel Corp.

    5,432       274,588  

KLA Corp.

    220       29,990  

Lam Research Corp.

    176       36,715  

Marvell Technology Group Ltd.

    1,440       37,814  

Maxim Integrated Products Inc.

    451       26,695  

Microchip Technology Inc.

    352       33,236  

Micron Technology Inc.(a)

    1,801       80,847  

Monolithic Power Systems Inc.

    66       9,779  

NVIDIA Corp.

    1,405       237,052  

QUALCOMM Inc.

    1,827       133,663  

Silicon Laboratories Inc.(a)

    77       8,640  

Skyworks Solutions Inc.

    264       22,514  

Texas Instruments Inc.

    1,211       151,387  
Security   Shares     Value  
Semiconductors (continued)  

Xilinx Inc.

    462     $ 52,765  
   

 

 

 
      1,455,787  
Software — 30.6%            

ACI Worldwide Inc.(a)

    220       7,383  

Activision Blizzard Inc.

    781       38,066  

Adobe Inc.(a)

    1,078       322,171  

Akamai Technologies Inc.(a)

    330       29,083  

ANSYS Inc.(a)

    154       31,280  

Aspen Technology Inc.(a)

    110       14,506  

Autodesk Inc.(a)

    459       71,682  

Black Knight Inc.(a)

    154       9,751  

Blackbaud Inc.

    99       9,009  

Box Inc., Class A(a)

    297       4,912  

Broadridge Financial Solutions Inc.

    154       19,576  

Cadence Design Systems Inc.(a)

    539       39,838  

CDK Global Inc.

    209       10,841  

Ceridian HCM Holding Inc.(a)

    211       11,248  

Cerner Corp.

    319       22,856  

Citrix Systems Inc.

    308       29,026  

Cloudera Inc.(a)(b)

    253       1,513  

CommVault Systems Inc.(a)

    99       4,499  

Cornerstone OnDemand Inc.(a)

    132       7,814  

Coupa Software Inc.(a)

    176       23,885  

DocuSign Inc.(a)

    383       19,809  

Dropbox Inc., Class A(a)

    726       17,105  

Electronic Arts Inc.(a)

    407       37,648  

Fair Isaac Corp.(a)

    55       19,108  

Fidelity National Information Services Inc.

    806       107,426  

Fiserv Inc.(a)

    854       90,037  

Guidewire Software Inc.(a)

    143       14,597  

HubSpot Inc.(a)

    77       13,761  

Intuit Inc.

    440       122,016  

j2 Global Inc.

    77       6,860  

Jack Henry & Associates Inc.

    132       18,440  

Manhattan Associates Inc.(a)(b)

    143       12,154  

Medidata Solutions Inc.(a)(b)

    110       10,051  

Microsoft Corp.

    18,808       2,562,966  

MSCI Inc.

    132       29,996  

New Relic Inc.(a)

    99       9,224  

Nuance Communications Inc.(a)(b)

    594       9,884  

Oracle Corp.

    6,481       364,880  

Paychex Inc.

    504       41,857  

Paycom Software Inc.(a)

    99       23,834  

Pegasystems Inc.

    88       6,653  

Progress Software Corp.

    121       5,238  

PTC Inc.(a)

    264       17,894  

RealPage Inc.(a)

    99       6,186  

salesforce.com Inc.(a)

    1,859       287,216  

ServiceNow Inc.(a)

    429       119,000  

Splunk Inc.(a)

    341       46,141  

SS&C Technologies Holdings Inc.

    286       13,714  

Synopsys Inc.(a)

    308       40,890  

Tableau Software Inc., Class A(a)

    165       27,972  

Teradata Corp.(a)

    264       9,668  

Twilio Inc., Class A(a)

    305       42,429  

Tyler Technologies Inc.(a)(b)

    66       15,401  

Veeva Systems Inc., Class A(a)

    242       40,148  

Verint Systems Inc.(a)

    132       7,639  

VMware Inc., Class A

    176       30,710  

Workday Inc., Class A(a)

    352       70,393  
 

 

 

38    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Schedule of Investments  (continued)

July 31, 2019

  

iShares® Evolved U.S. Technology ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Software (continued)  

Zynga Inc., Class A(a)

    1,199     $ 7,650  
   

 

 

 
      5,035,534  
Telecommunications — 4.1%            

Arista Networks Inc.(a)

    132       36,095  

Ciena Corp.(a)

    264       11,938  

Cisco Systems Inc.

    10,120       560,648  

CommScope Holding Co. Inc.(a)(b)

    176       2,513  

Juniper Networks Inc.

    781       21,103  

LogMeIn Inc.

    110       8,357  

Motorola Solutions Inc.

    176       29,209  

Zayo Group Holdings Inc.(a)

    187       6,308  
   

 

 

 
      676,171  
Transportation — 0.2%            

Expeditors International of Washington Inc.

    143       10,918  

FedEx Corp.

    55       9,379  

XPO Logistics Inc.(a)(b)

    44       2,969  
   

 

 

 
      23,266  
   

 

 

 

Total Common Stocks — 98.7%
(Cost: $14,882,941)

      16,258,945  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 2.1%            

BlackRock Cash Funds: Institutional,
SL Agency Shares, 2.45%(c)(d)(e)

    149,562       149,637  
Security   Shares     Value  
Money Market Funds (continued)  

BlackRock Cash Funds: Treasury,
SL Agency Shares, 2.25%(c)(d)

    188,000     $ 188,000  
   

 

 

 
      337,637  
   

 

 

 

Total Short-Term Investments — 2.1%
(Cost: $337,628)

 

    337,637  
   

 

 

 

Total Investments in Securities — 100.8%
(Cost: $15,220,569)

 

    16,596,582  

Other Assets, Less Liabilities — (0.8)%

 

    (126,159
   

 

 

 

Net Assets — 100.0%

    $ 16,470,423  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period-end.

(e) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the year ended July 31, 2019, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:

 

 

 

Affiliated Issuer

   

Shares
Held at
07/31/18
 
 
 
     Net Activity       

Shares
Held at
07/31/19
 
 
 
    
Value at
07/31/19
 
 
     Income      
Net Realized
Gain (Loss)
 
(a) 
   


Change in
Unrealized
Appreciation
(Depreciation)
 
 
 
 

 

 

BlackRock Cash Funds: Institutional,
SL Agency Shares

    51,044        98,518        149,562      $ 149,637      $ 128 (b)    $ 7     $ 6  

BlackRock Cash Funds: Treasury,
SL Agency Shares

    43,533        144,467        188,000        188,000        1,268              
          

 

 

    

 

 

   

 

 

   

 

 

 
           $ 337,637      $ 1,396     $ 7     $ 6  
          

 

 

    

 

 

   

 

 

   

 

 

 

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

 
  (b) 

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2019. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2        Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 16,258,945        $        $        $ 16,258,945  

Money Market Funds

     337,637                            337,637  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 16,596,582        $         —        $         —        $ 16,596,582  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

SCHEDULE OF INVESTMENTS      39  


 

Statements of Assets and Liabilities

July 31, 2019

 

    iShares
Evolved
U.S. Consumer
Staples ETF
    

iShares

Evolved
U.S. Discretionary
Spending ETF

     iShares
Evolved
U.S. Financials
ETF
     iShares
Evolved
U.S. Healthcare
Staples ETF
 

 

 

ASSETS

          

Investments in securities, at value (including securities on loan)(a):

          

Unaffiliated(b)

  $ 4,113,518      $ 5,862,265      $ 4,941,650      $ 7,310,824  

Affiliated(c)

    47,021        56,828        25,490        300,070  

Cash

    332        919        536        80  

Receivables:

          

Investments sold

                  17,393         

Securities lending income — Affiliated

    15        49        2        66  

Dividends

    4,908        3,638        3,706        4,679  
 

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

    4,165,794        5,923,699        4,988,777        7,615,719  
 

 

 

    

 

 

    

 

 

    

 

 

 

LIABILITIES

          

Collateral on securities loaned, at value

    28,023        27,792        1,490        250,063  

Payables:

          

Investments purchased

                  15,358         

Investment advisory fees

    633        909        754        1,131  
 

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

    28,656        28,701        17,602        251,194  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 4,137,138      $ 5,894,998      $ 4,971,175      $ 7,364,525  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF:

          

Paid-in capital

  $ 3,703,786      $ 4,957,446      $ 4,938,160      $ 6,520,471  

Accumulated earnings

    433,352        937,552        33,015        844,054  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 4,137,138      $ 5,894,998      $ 4,971,175      $ 7,364,525  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    150,000        200,000        200,000        250,000  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 27.58      $ 29.47      $ 24.86      $ 29.46  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    None        None        None        None  
 

 

 

    

 

 

    

 

 

    

 

 

 

(a) Securities loaned, at value

  $ 27,068      $ 27,010      $ 1,434      $ 240,348  

(b) Investments, at cost — Unaffiliated

  $ 3,686,590      $ 4,947,805      $ 4,873,323      $ 6,529,674  

(c)  Investments, at cost — Affiliated

  $ 47,021      $ 56,825      $ 25,490      $ 300,064  

See notes to financial statements.

 

 

40    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Statements of Assets and Liabilities  (continued)

July 31, 2019

 

    iShares
Evolved
U.S. Innovative
Healthcare
ETF
     iShares
Evolved
U.S. Media and
Entertainment
ETF
    

iShares

Evolved
U.S. Technology
ETF

 

 

 

ASSETS

       

Investments in securities, at value (including securities on loan)(a):

       

Unaffiliated(b)

  $ 4,870,575      $ 7,003,484      $ 16,258,945  

Affiliated(c)

    260,261        138,140        337,637  

Cash

    565        308        650  

Receivables:

       

Investments sold

                  49,527  

Securities lending income — Affiliated

    140        35        13  

Capital shares sold

                  18,249  

Dividends

    5,235        2,043        2,021  
 

 

 

    

 

 

    

 

 

 

Total assets

    5,136,776        7,144,010        16,667,042  
 

 

 

    

 

 

    

 

 

 

LIABILITIES

       

Collateral on securities loaned, at value

    187,199        87,102        149,620  

Payables:

       

Investments purchased

                  44,929  

Investment advisory fees

    770        1,082        2,070  
 

 

 

    

 

 

    

 

 

 

Total liabilities

    187,969        88,184        196,619  
 

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 4,948,807      $ 7,055,826      $ 16,470,423  
 

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF:

       

Paid-in capital

  $ 4,918,256      $ 6,327,114      $ 15,069,435  

Accumulated earnings

    30,551        728,712        1,400,988  
 

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 4,948,807      $ 7,055,826      $ 16,470,423  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    200,000        250,000        550,000  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 24.74      $ 28.22      $ 29.95  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

    None        None        None  
 

 

 

    

 

 

    

 

 

 

(a) Securities loaned, at value

  $ 179,990      $ 83,547      $ 145,707  

(b) Investments, at cost — Unaffiliated

  $ 4,923,872      $ 6,476,622      $ 14,882,941  

(c)  Investments, at cost — Affiliated

  $ 260,217      $ 138,130      $ 337,628  

See notes to financial statements.

 

 

FINANCIAL STATEMENTS      41  


 

Statements of Operations

Year Ended July 31, 2019

 

    iShares
Evolved
U.S. Consumer
Staples ETF
   

iShares

Evolved
U.S. Discretionary
Spending ETF

     iShares
Evolved
U.S. Financials
ETF
    iShares
Evolved
U.S. Healthcare
Staples ETF
 

 

 

INVESTMENT INCOME

        

Dividends — Unaffiliated

  $ 104,654     $ 87,074      $ 108,181     $ 59,952  

Dividends — Affiliated

    1,118       695        804       1,647  

Securities lending income — Affiliated — net

    35       296        5       231  

Foreign taxes withheld

                 (25      
 

 

 

   

 

 

    

 

 

   

 

 

 

Total investment income

    105,807       88,065        108,965       61,830  
 

 

 

   

 

 

    

 

 

   

 

 

 

EXPENSES

        

Investment advisory fees

    6,873       9,884        8,423       9,808  
 

 

 

   

 

 

    

 

 

   

 

 

 

Total expenses

    6,873       9,884        8,423       9,808  
 

 

 

   

 

 

    

 

 

   

 

 

 

Net investment income

    98,934       78,181        100,542       52,022  
 

 

 

   

 

 

    

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

        

Net realized gain (loss) from:

        

Investments — Unaffiliated

    8,803       33,848        (20,809     94,306  

Investments — Affiliated

    (6     32              1  

In-kind redemptions — Unaffiliated

    14                    115,996  
 

 

 

   

 

 

    

 

 

   

 

 

 

Net realized gain (loss)

    8,811       33,880        (20,809     210,303  
 

 

 

   

 

 

    

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

        

Investments — Unaffiliated

    409,474       506,932        72,632       251,230  

Investments — Affiliated

                       5  
 

 

 

   

 

 

    

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

    409,474       506,932        72,632       251,235  
 

 

 

   

 

 

    

 

 

   

 

 

 

Net realized and unrealized gain

    418,285       540,812        51,823       461,538  
 

 

 

   

 

 

    

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 517,219     $ 618,993      $ 152,365     $ 513,560  
 

 

 

   

 

 

    

 

 

   

 

 

 

See notes to financial statements.

 

 

42    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Statements of Operations  (continued)

Year Ended July 31, 2019

 

   



iShares

Evolved
U.S. Innovative
Healthcare

ETF

 

 
 
 

 

   




iShares

Evolved
U.S. Media and
Entertainment
ETF

 

 
 
 
 

   



iShares

Evolved
U.S. Technology
ETF

 

 
 
 

 

 

INVESTMENT INCOME

     

Dividends — Unaffiliated

  $ 79,512     $ 60,985     $ 67,194  

Dividends — Affiliated

    1,033       2,313       1,268  

Securities lending income — Affiliated — net

    2,450       1,468       128  

Foreign taxes withheld

          (50      
 

 

 

   

 

 

   

 

 

 

Total investment income

    82,995       64,716       68,590  
 

 

 

   

 

 

   

 

 

 

EXPENSES

     

Investment advisory fees

    9,165       9,917       12,029  
 

 

 

   

 

 

   

 

 

 

Total expenses

    9,165       9,917       12,029  
 

 

 

   

 

 

   

 

 

 

Net investment income

    73,830       54,799       56,561  
 

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

     

Net realized gain (loss) from:

     

Investments — Unaffiliated

    78,930       208,241       40,928  

Investments — Affiliated

    14       12       7  
 

 

 

   

 

 

   

 

 

 

Net realized gain

    78,944       208,253       40,935  
 

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

     

Investments — Unaffiliated

    (309,492     249,971       1,019,554  

Investments — Affiliated

    36       (28     6  
 

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

    (309,456     249,943       1,019,560  
 

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

    (230,512     458,196       1,060,495  
 

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $ (156,682   $ 512,995     $ 1,117,056  
 

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

FINANCIAL STATEMENTS      43  


 

Statements of Changes in Net Assets

 

    iShares
Evolved U.S. Consumer Staples
ETF
    iShares
Evolved U.S. Discretionary
Spending ETF
 
   
Year Ended
07/31/19
 
 
   

Period From
03/21/18

to 07/31/18

 
(a)  

 

   
Year Ended
07/31/19
 
 
   

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

INCREASE (DECREASE) IN NET ASSETS

       

OPERATIONS

       

Net investment income

  $ 98,934     $ 57,952     $ 78,181     $ 22,619  

Net realized gain

    8,811       820       33,880       465  

Net change in unrealized appreciation (depreciation)

    409,474       17,454       506,932       407,531  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in net assets resulting from operations

    517,219       76,226       618,993       430,615  
 

 

 

   

 

 

   

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(b)(c)

       

Decrease in net assets resulting from distributions to shareholders

    (135,321     (32,423     (92,875     (18,716
 

 

 

   

 

 

   

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

       

Net increase in net assets derived from capital share transactions

          3,711,437             4,956,981  
 

 

 

   

 

 

   

 

 

   

 

 

 

NET ASSETS(c)

       

Total increase in net assets

    381,898       3,755,240       526,118       5,368,880  

Beginning of period

    3,755,240             5,368,880        
 

 

 

   

 

 

   

 

 

   

 

 

 

End of period

  $ 4,137,138     $ 3,755,240     $ 5,894,998     $ 5,368,880  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Prior year distribution character information and undistributed net investment income has been modified or removed to conform with current year Regulation S-X presentation changes. Refer to Note 11 for this prior year information.

See notes to financial statements.

 

 

44    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Statements of Changes in Net Assets  (continued)

 

    iShares
Evolved U.S. Financials ETF
    iShares
Evolved U.S. Healthcare Staples
ETF
 
   
Year Ended
07/31/19
 
 
   

Period From
03/21/18

to 07/31/18

 
(a)  

 

   
Year Ended
07/31/19
 
 
   

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

INCREASE (DECREASE) IN NET ASSETS

       

OPERATIONS

       

Net investment income

  $ 100,542     $ 28,245     $ 52,022     $ 15,993  

Net realized gain (loss)

    (20,809     (21,490     210,303       (13

Net change in unrealized appreciation (depreciation)

    72,632       (4,305     251,235       529,921  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in net assets resulting from operations

    152,365       2,450       513,560       545,901  
 

 

 

   

 

 

   

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(b)(c)

       

Decrease in net assets resulting from distributions to shareholders

    (100,143     (21,657     (80,138     (11,128
 

 

 

   

 

 

   

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

       

Net increase in net assets derived from capital share transactions

          4,938,160       1,435,729       4,960,601  
 

 

 

   

 

 

   

 

 

   

 

 

 

NET ASSETS(c)

       

Total increase in net assets

    52,222       4,918,953       1,869,151       5,495,374  

Beginning of period

    4,918,953             5,495,374        
 

 

 

   

 

 

   

 

 

   

 

 

 

End of period

  $ 4,971,175     $ 4,918,953     $ 7,364,525     $ 5,495,374  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Prior year distribution character information and undistributed net investment income has been modified or removed to conform with current year Regulation S-X presentation changes. Refer to Note 11 for this prior year information.

See notes to financial statements.

 

 

FINANCIAL STATEMENTS      45  


Statements of Changes in Net Assets  (continued)

 

    iShares
Evolved U.S. Innovative
Healthcare ETF
       iShares
Evolved U.S. Media and
Entertainment ETF
 
   
Year Ended
07/31/19
 
 
      

Period From
03/21/18

to 07/31/18

 
(a)  

 

      
Year Ended
07/31/19
 
 
      

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

INCREASE (DECREASE) IN NET ASSETS

                

OPERATIONS

                

Net investment income

  $ 73,830        $ 21,582        $ 54,799        $ 18,568  

Net realized gain

    78,944          26,905          208,253          13,093  

Net change in unrealized appreciation (depreciation)

    (309,456        256,203          249,943          276,929  
 

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) in net assets resulting from operations

    (156,682        304,690          512,995          308,590  
 

 

 

      

 

 

      

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(b)(c)

                

Decrease in net assets resulting from distributions to shareholders

    (100,052        (17,405        (81,138        (11,735
 

 

 

      

 

 

      

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

                

Net increase in net assets derived from capital share transactions

             4,918,256          1,347,171          4,979,943  
 

 

 

      

 

 

      

 

 

      

 

 

 

NET ASSETS(c)

                

Total increase (decrease) in net assets

    (256,734        5,205,541          1,779,028          5,276,798  

Beginning of period

    5,205,541                   5,276,798           
 

 

 

      

 

 

      

 

 

      

 

 

 

End of period

  $ 4,948,807        $ 5,205,541        $ 7,055,826        $ 5,276,798  
 

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Prior year distribution character information and undistributed net investment income has been modified or removed to conform with current year Regulation S-X presentation changes. Refer to Note 11 for this prior year information.

See notes to financial statements.

 

 

46    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Statements of Changes in Net Assets  (continued)

 

     iShares
Evolved U.S. Technology ETF
 
    
Year Ended
07/31/19
 
 
      

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

INCREASE (DECREASE) IN NET ASSETS

       

OPERATIONS

       

Net investment income

   $ 56,561        $ 12,558  

Net realized gain

     40,935          144  

Net change in unrealized appreciation (depreciation)

     1,019,560          356,453  
  

 

 

      

 

 

 

Net increase in net assets resulting from operations

     1,117,056          369,155  
  

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(b)(c)

       

Decrease in net assets resulting from distributions to shareholders

     (74,296        (10,692
  

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

       

Net increase in net assets derived from capital share transactions

     10,161,391          4,907,809  
  

 

 

      

 

 

 

NET ASSETS(c)

       

Total increase in net assets

     11,204,151          5,266,272  

Beginning of period

     5,266,272           
  

 

 

      

 

 

 

End of period

   $ 16,470,423        $ 5,266,272  
  

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Prior year distribution character information and undistributed net investment income has been modified or removed to conform with current year Regulation S-X presentation changes. Refer to Note 11 for this prior year information.

See notes to financial statements.

 

 

FINANCIAL STATEMENTS      47  


Financial Highlights

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Consumer Staples ETF  
   
Year Ended
07/31/19
 
 
    

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 25.03        $ 24.62  
 

 

 

      

 

 

 

Net investment income(b)

    0.66          0.31 (c)  

Net realized and unrealized gain(d)

    2.80          0.26  
 

 

 

      

 

 

 

Net increase from investment operations

    3.46          0.57  
 

 

 

      

 

 

 
Distributions(e)                 

From net investment income

    (0.85        (0.16

From net realized gain

    (0.06         
 

 

 

      

 

 

 

Total distributions

    (0.91        (0.16
 

 

 

      

 

 

 

Net asset value, end of period

  $ 27.58        $ 25.03  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    14.23        2.34 %(f) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(g) 
 

 

 

      

 

 

 

Net investment income

    2.59        3.58 %(c)(g) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 4,137        $ 3,755  
 

 

 

      

 

 

 

Portfolio turnover rate(h)

    9        0 %(f)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Includes a special distribution from Dr Pepper Snapple Group Inc. Excluding such special distribution, the net investment income would have been $0.21 per share and 2.39% of average net assets.

(d) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(e) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(f) 

Not annualized.

(g) 

Annualized.

(h) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

48    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Discretionary Spending ETF  
   
Year Ended
07/31/19
 
 
    

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 26.84        $ 24.95  
 

 

 

      

 

 

 

Net investment income(b)

    0.39          0.12  

Net realized and unrealized gain(c)

    2.70          1.86  
 

 

 

      

 

 

 

Net increase from investment operations

    3.09          1.98  
 

 

 

      

 

 

 
Distributions(d)                 

From net investment income

    (0.41        (0.09

From net realized gain

    (0.05         
 

 

 

      

 

 

 

Total distributions

    (0.46        (0.09
 

 

 

      

 

 

 

Net asset value, end of period

  $ 29.47        $ 26.84  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    11.73        7.96 %(e) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(f) 
 

 

 

      

 

 

 

Net investment income

    1.42        1.25 %(f) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 5,895        $ 5,369  
 

 

 

      

 

 

 

Portfolio turnover rate(g)

    11        0 %(e)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

FINANCIAL HIGHLIGHTS      49  


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Financials ETF  
   
Year Ended
07/31/19
 
 
       

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 24.59        $ 24.98  
 

 

 

      

 

 

 

Net investment income(b)

    0.50          0.15  

Net realized and unrealized gain (loss)(c)

    0.27          (0.43
 

 

 

      

 

 

 

Net increase (decrease) from investment operations

    0.77          (0.28
 

 

 

      

 

 

 
Distributions(d)                 

From net investment income

    (0.50        (0.11
 

 

 

      

 

 

 

Total distributions

    (0.50        (0.11
 

 

 

      

 

 

 

Net asset value, end of period

  $ 24.86        $ 24.59  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    3.35        (1.11 )%(e)(f) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(g) 
 

 

 

      

 

 

 

Net investment income

    2.15        1.65 %(g) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 4,971        $ 4,919  
 

 

 

      

 

 

 

Portfolio turnover rate(h)

    10        13 %(e)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Includes payment received from an affiliate, which impacted the Fund’s total return. Excluding the payment from an affiliate, the Fund’s total return would have been -1.40%.

(g) 

Annualized.

(h) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

50    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Healthcare Staples ETF  
   
Year Ended
07/31/19
 
 
       

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 27.48        $ 24.86  
 

 

 

      

 

 

 

Net investment income(b)

    0.27          0.08  

Net realized and unrealized gain(c)

    2.11          2.60  
 

 

 

      

 

 

 

Net increase from investment operations

    2.38          2.68  
 

 

 

      

 

 

 
Distributions(d)                 

From net investment income

    (0.28        (0.06

From net realized gain

    (0.12         
 

 

 

      

 

 

 

Total distributions

    (0.40        (0.06
 

 

 

      

 

 

 

Net asset value, end of period

  $ 29.46        $ 27.48  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    8.77        10.77 %(e) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(f) 
 

 

 

      

 

 

 

Net investment income

    0.95        0.87 %(f) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 7,365        $ 5,495  
 

 

 

      

 

 

 

Portfolio turnover rate(g)

    12        0 %(e)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

FINANCIAL HIGHLIGHTS      51  


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Innovative Healthcare ETF  
   
Year Ended
07/31/19
 
 
       

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 26.03        $ 24.97  
 

 

 

      

 

 

 

Net investment income(b)

    0.37          0.11  

Net realized and unrealized gain (loss)(c)

    (1.15        1.04  
 

 

 

      

 

 

 

Net increase (decrease) from investment operations

    (0.78        1.15  
 

 

 

      

 

 

 
Distributions(d)                 

From net investment income

    (0.36        (0.09

From net realized gain

    (0.15         
 

 

 

      

 

 

 

Total distributions

    (0.51        (0.09
 

 

 

      

 

 

 

Net asset value, end of period

  $ 24.74        $ 26.03  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    (3.04 )%         4.62 %(e) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(f) 
 

 

 

      

 

 

 

Net investment income

    1.45        1.25 %(f) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 4,949        $ 5,206  
 

 

 

      

 

 

 

Portfolio turnover rate(g)

    8        3 %(e)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

52    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Media and Entertainment ETF  
   
Year Ended
07/31/19
 
 
       

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 26.38        $ 25.05  
 

 

 

      

 

 

 

Net investment income(b)

    0.26          0.10  

Net realized and unrealized gain(c)

    1.97          1.29  
 

 

 

      

 

 

 

Net increase from investment operations

    2.23          1.39  
 

 

 

      

 

 

 
Distributions(d)                 

From net investment income

    (0.26        (0.06

From net realized gain

    (0.13         
 

 

 

      

 

 

 

Total distributions

    (0.39        (0.06
 

 

 

      

 

 

 

Net asset value, end of period

  $ 28.22        $ 26.38  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    8.64        5.54 %(e) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(f) 
 

 

 

      

 

 

 

Net investment income

    0.99        1.04 %(f) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 7,056        $ 5,277  
 

 

 

      

 

 

 

Portfolio turnover rate(g)

    10        0 %(e)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

FINANCIAL HIGHLIGHTS      53  


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    iShares Evolved U.S. Technology ETF  
   
Year Ended
07/31/19
 
 
       

Period From
03/21/18

to 07/31/18

 
(a)  

 

 

 

Net asset value, beginning of period

  $ 26.33        $ 24.89  
 

 

 

      

 

 

 

Net investment income(b)

    0.23          0.06  

Net realized and unrealized gain(c)

    3.73          1.43  
 

 

 

      

 

 

 

Net increase from investment operations

    3.96          1.49  
 

 

 

      

 

 

 
Distributions(d)                 

From net investment income

    (0.27        (0.05

From net realized gain

    (0.07         
 

 

 

      

 

 

 

Total distributions

    (0.34        (0.05
 

 

 

      

 

 

 

Net asset value, end of period

  $ 29.95        $ 26.33  
 

 

 

      

 

 

 

Total Return

      

Based on net asset value

    15.27        6.00 %(e) 
 

 

 

      

 

 

 

Ratios to Average Net Assets

      

Total expenses

    0.18        0.18 %(f) 
 

 

 

      

 

 

 

Net investment income

    0.85        0.70 %(f) 
 

 

 

      

 

 

 

Supplemental Data

      

Net assets, end of period (000)

  $ 16,470        $ 5,266  
 

 

 

      

 

 

 

Portfolio turnover rate(g)

    7        0 %(e)  
 

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Not annualized.

(f) 

Annualized.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

54    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements

 

1.  

ORGANIZATION

iShares U.S. ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Delaware statutory trust and is authorized to have multiple series or portfolios.

These financial statements relate only to the following funds (each, a “Fund,” and collectively, the “Funds”):

 

iShares ETF   Diversification    
Classification    
 

Evolved U.S. Consumer Staples

    Non-diversified      

Evolved U.S. Discretionary Spending

    Non-diversified      

Evolved U.S. Financials

    Non-diversified      

Evolved U.S. Healthcare Staples

    Non-diversified      

Evolved U.S. Innovative Healthcare

    Non-diversified      

Evolved U.S. Media and Entertainment

    Non-diversified      

Evolved U.S. Technology

    Non-diversified      

 

2.  

SIGNIFICANT ACCOUNTING POLICIES

The following significant accounting policies are consistently followed by each Fund in the preparation of its financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies.

Investment Transactions and Income Recognition: Investment transactions are accounted for on trade date. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recognized on the ex-dividend date, net of any foreign taxes withheld at source. Any taxes withheld that are reclaimable from foreign tax authorities are reflected in tax reclaims receivable. Distributions received by the Funds may include a return of capital that is estimated by management. Such amounts are recorded as a reduction of the cost of investments or reclassified to capital gains. Upon notification from issuers, some of the dividend income received from a real estate investment trust may be re-designated as a return of capital or capital gain. Non-cash dividends, if any, are recognized on the ex-dividend date and recorded as non-cash dividend income at fair value. Interest income is accrued daily.

Foreign Taxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund invests. These foreign taxes, if any, are paid by each Fund and are reflected in its statement of operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “other foreign taxes”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of July 31, 2019, if any, are disclosed in the statement of assets and liabilities.

In-kind Redemptions: For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the Funds. Because such gains or losses are not taxable to the Funds and are not distributed to existing Fund shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the Funds’ tax year. These reclassifications have no effect on net assets or net asset value per share.

Distributions: Dividends and distributions paid by each Fund are recorded on the ex-dividend dates. Distributions are determined on a tax basis and may differ from net investment income and net realized capital gains for financial reporting purposes. Dividends and distributions are paid in U.S. dollars and cannot be automatically reinvested in additional shares of the Funds.

Indemnifications: In the normal course of business, each Fund enters into contracts that contain a variety of representations that provide general indemnification. The Funds’ maximum exposure under these arrangements is unknown because it involves future potential claims against the Funds, which cannot be predicted with any certainty.

 

3.  

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund’s listing exchange is open and, for financial reporting purposes, as of the report date should the reporting period end on a day that the Fund’s listing exchange is not open. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. A fund determines the fair value of its financial instruments using various independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). The BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) is the committee formed by management to develop global pricing policies and procedures and to oversee the pricing function for all financial instruments.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

 

 

NOTES TO FINANCIAL STATEMENTS      55  


Notes to Financial Statements  (continued)

 

 

   

Equity investments traded on a recognized securities exchange are valued at that day’s last traded price or official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day are valued at the last traded price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published net asset value (“NAV”).

If events (e.g., a company announcement, market volatility or a natural disaster) occur that are expected to materially affect the value of an investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, in accordance with policies approved by the Board as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Global Valuation Committee include market approach, income approach and the cost approach. Valuation techniques used under these approaches take into consideration inputs that include but are not limited to (i) attributes specific to the investment; (ii) the principal market for the investment; (iii) the customary participants in the principal market for the investment; (iv) data assumptions by market participants for the investment, if reasonably available; (v) quoted prices for similar investments in active markets; and (vi) other inputs, such as future cash flows, interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and/or default rates.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 — Unadjusted price quotations in active markets for identical assets or liabilities;

 

   

Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not considered to be active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs; and

 

   

Level 3 — Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, (including the Global Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgement exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The fair value hierarchy for each Fund’s investments is included in its schedule of investments. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

 

4.  

SECURITIES AND OTHER INVESTMENTS

Securities Lending: Each Fund may lend its securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by an approved bank, or securities issued or guaranteed by the U.S. government. The initial collateral received by each Fund is required to have a value of at least 102% of the current market value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund or excess collateral is returned by the Fund, on the next business day. During the term of the loan, each Fund is entitled to all distributions made on or in respect of the loaned securities but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of July 31, 2019, any securities on loan were collateralized by cash and/or U.S. government obligations. Cash collateral received was invested in money market funds managed by BlackRock Fund Advisors (“BFA”), the Funds’ investment adviser, or its affiliates and is disclosed in the schedules of investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan for each Fund, if any, are also disclosed in its schedule of investments. The market value of any securities on loan as of July 31, 2019 and the value of the related cash collateral are disclosed in the statements of assets and liabilities.

Securities lending transactions are entered into by a fund under Master Securities Lending Agreements (each, an “MSLA”) which provide the right, in the event of default (including bankruptcy or insolvency) for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. The value of the collateral is typically greater than the market value of the securities loaned, leaving the lender with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the fund can reinvest cash collateral received in connection with loaned securities.

 

 

56    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements  (continued)

 

The following table is a summary of the securities lending agreements by counterparty which are subject to offset under an MSLA as of July 31, 2019:

 

 

 

iShares ETF and Counterparty

   
Market Value of
Securities on Loan
 
 
    
Cash Collateral
Received(a)
 
 
    
Non-Cash Collateral
Received
 
 
     Net Amount  

 

 

Evolved U.S. Consumer Staples

          

Barclays Capital Inc.

  $ 17,539      $ 17,539      $      $  

HSBC Bank PLC

    5,306        5,306                

JPMorgan Securities LLC

    4,223        4,223                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 27,068      $ 27,068      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Discretionary Spending

          

BofA Securities, Inc.

  $ 4,125      $ 4,125      $      $  

Citigroup Global Markets Inc.

    2,205        2,205                

Credit Suisse Securities (USA) LLC

    2,620        2,620                

HSBC Bank PLC

    2,584        2,584                

Morgan Stanley & Co. LLC (U.S. Equity Securities Lending)

    14,186        14,186                

RBC Capital Markets LLC

    1,290        1,290                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 27,010      $ 27,010      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Financials

          

Morgan Stanley & Co. LLC (U.S. Equity Securities Lending)

  $ 1,434      $ 1,434      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Healthcare Staples

          

Barclays Capital Inc.

  $ 1,419      $ 1,419      $      $  

Citigroup Global Markets Inc.

    17,914        17,914                

Credit Suisse Securities (USA) LLC

    35,180        35,180                

HSBC Bank PLC

    7,865        7,865                

Morgan Stanley & Co. LLC (U.S. Equity Securities Lending)

    164,730        164,730                

UBS AG

    13,240        13,240                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 240,348      $ 240,348      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Innovative Healthcare

          

Barclays Capital Inc.

  $ 8,703      $ 8,703      $      $  

Citigroup Global Markets Inc.

    26,893        26,893                

Credit Suisse AG Dublin Branch

    1,376        1,376                

Credit Suisse Securities (USA) LLC

    1,506        1,506                

HSBC Bank PLC

    10,985        10,985                

Jefferies LLC

    4,954        4,954                

Morgan Stanley & Co. LLC (U.S. Equity Securities Lending)

    69,517        69,517                

TD Prime Services LLC

    46,144        46,144                

UBS AG

    9,912        9,912                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 179,990      $ 179,990      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Media and Entertainment

          

Citigroup Global Markets Inc.

  $ 3,466      $ 3,466      $      $  

Credit Suisse Securities (USA) LLC

    80,081        80,081                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 83,547      $ 83,547      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

Evolved U.S. Technology

          

Barclays Capital Inc.

  $ 54,939      $ 54,939      $      $  

Citigroup Global Markets Inc.

    4,419        4,419                

Credit Suisse Securities (USA) LLC

    12,885        12,885                

HSBC Bank PLC

    50,178        50,178                

Morgan Stanley & Co. LLC (U.S. Equity Securities Lending)

    12,754        12,754                

TD Prime Services LLC

    10,532        10,532                
 

 

 

    

 

 

    

 

 

    

 

 

 
  $ 145,707      $ 145,707      $      $  
 

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Collateral received in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Fund’s statement of assets and liabilities.

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, each Fund benefits from a borrower default indemnity provided by BlackRock, Inc. (“BlackRock”). BlackRock’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value of the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of the loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by each Fund.

 

 

NOTES TO FINANCIAL STATEMENTS      57  


Notes to Financial Statements  (continued)

 

 

5.  

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory Fees: Pursuant to an Investment Advisory Agreement with the Trust, BFA manages the investment of each Fund’s assets. BFA is a California corporation indirectly owned by BlackRock. Under the Investment Advisory Agreement, BFA is responsible for substantially all expenses of the Funds, except (i) interest and taxes; (ii) brokerage commissions and other expenses connected with the execution of portfolio transactions; (iii) distribution fees; (iv) the advisory fee payable to BFA; and (v) litigation expenses and any extraordinary expenses (in each case as determined by a majority of the independent trustees).

For its investment advisory services to each Fund, BFA is entitled to an annual investment advisory fee, accrued daily and paid monthly by the Funds, based on the average daily net assets of each Fund as follows:

 

iShares ETF   Investment Advisory Fee  

Evolved U.S. Consumer Staples

    0.18

Evolved U.S. Discretionary Spending

    0.18  

Evolved U.S. Financials

    0.18  

Evolved U.S. Healthcare Staples

    0.18  

Evolved U.S. Innovative Healthcare

    0.18  

Evolved U.S. Media and Entertainment

    0.18  

Evolved U.S. Technology

    0.18  

Distributor: BlackRock Investments, LLC, an affiliate of BFA, is the distributor for each Fund. Pursuant to the distribution agreement, BFA is responsible for any fees or expenses for distribution services provided to the Funds.

Securities Lending: The U.S. Securities and Exchange Commission (the “SEC”) has issued an exemptive order which permits BlackRock Institutional Trust Company, N.A. (“BTC”), an affiliate of BFA, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BTC bears all operational costs directly related to securities lending. Each Fund is responsible for fees in connection with the investment of cash collateral received for securities on loan in a money market fund managed by BFA, or its affiliates, however, BTC has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees each Fund bears to an annual rate of 0.04% (the “collateral investment fees”). Securities lending income is equal to the total of income earned from the reinvestment of cash collateral (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities. Each Fund retains a portion of securities lending income and remits the remaining portion to BTC as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, each Fund retains 73.5% of securities lending income (which excludes collateral investment fees) and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across all 1940 Act iShares exchange-traded funds (the “iShares ETF Complex”) in a given calendar year exceeds a specified threshold, each Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year 80% of securities lending income and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

Prior to January 1, 2019, the Fund retained 71.5% of securities lending income (which excludes collateral investment fees) and the amount retained was not less than 65% of the total of securities lending income plus the collateral investment fees. In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across all the iShares ETF Complex in a given calendar year exceeds a specified threshold, each Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year 75% of securities lending income and the amount retained can never be less than 65% of the total of securities lending income plus the collateral investment fees.

The share of securities lending income earned by each Fund is shown as securities lending income — affiliated — net in its statement of operations. For the year ended July 31, 2019, the Funds paid BTC the following amounts for securities lending agent services:

 

iShares ETF   Fees Paid    
to BTC    
 

Evolved U.S. Consumer Staples

  $ 14      

Evolved U.S. Discretionary Spending

    117      

Evolved U.S. Financials

    2      

Evolved U.S. Healthcare Staples

    92      

Evolved U.S. Innovative Healthcare

    930      

Evolved U.S. Media and Entertainment

    569      

Evolved U.S. Technology

    56      

Officers and Trustees: Certain officers and/or trustees of the Trust are officers and/or trustees of BlackRock or its affiliates.

Each Fund may invest its positive cash balances in certain money market funds managed by BFA or an affiliate. The income earned on these temporary cash investments is shown as dividends — affiliated in the statement of operations.

 

 

58    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements  (continued)

 

6.  

PURCHASES AND SALES

For the year ended July 31, 2019, purchases and sales of investments, excluding in-kind transactions and short-term investments, were as follows:

 

iShares ETF   Purchases      Sales      

Evolved U.S. Consumer Staples

  $ 504,165      $ 342,809      

Evolved U.S. Discretionary Spending

    619,258        630,656      

Evolved U.S. Financials

    511,341        452,542      

Evolved U.S. Healthcare Staples

    821,089        633,584      

Evolved U.S. Innovative Healthcare

    387,085        452,366      

Evolved U.S. Media and Entertainment

    1,039,129        559,378      

Evolved U.S. Technology

    508,647        575,359      

For the year ended July 31, 2019, in-kind transactions were as follows:

 

iShares ETF   In-kind
Purchases
     In-kind    
Sales    
 

Evolved U.S. Healthcare Staples

  $ 2,705,125      $ 1,298,450      

Evolved U.S. Media and Entertainment

    1,337,487        —      

Evolved U.S. Technology

    10,059,501        —      

 

7.  

INCOME TAX INFORMATION

Each Fund is treated as an entity separate from the Trust’s other funds for federal income tax purposes. It is the policy of each Fund to qualify as a regulated investment company by complying with the provisions applicable to regulated investment companies, as defined under Subchapter M of the Internal Revenue Code of 1986, as amended, and to annually distribute substantially all of its ordinary income and any net capital gains (taking into account any capital loss carryforwards) sufficient to relieve it from all, or substantially all, federal income and excise taxes. Accordingly, no provision for federal income taxes is required.

Management has analyzed tax laws and regulations and their application to the Funds as of July 31, 2019, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or NAV per share. As of July 31, 2019, the following permanent differences attributable to the use of equalization and realized gains (losses) from in-kind redemptions, were reclassified to the following accounts:

 

iShares ETF   Paid-in Capital      Accumulated
Earnings
 

Evolved U.S. Consumer Staples

  $ 14      $ (14

Evolved U.S. Discretionary Spending

    465        (465

Evolved U.S. Healthcare Staples

    124,141        (124,141

Evolved U.S. Technology

    235        (235

The tax character of distributions paid was as follows:

 

 

 
iShares ETF   Year Ended
07/31/19
     Period Ended
07/31/18
 

 

 

Evolved U.S. Consumer Staples

    

Ordinary income

  $ 135,321      $ 32,423  
 

 

 

    

 

 

 

Evolved U.S. Discretionary Spending

    

Ordinary income

  $ 92,875      $ 18,716  
 

 

 

    

 

 

 

Evolved U.S. Financials

    

Ordinary income

  $ 100,143      $ 21,657  
 

 

 

    

 

 

 

Evolved U.S. Healthcare Staples

    

Ordinary income

  $ 80,138      $ 11,128  
 

 

 

    

 

 

 

Evolved U.S. Innovative Healthcare

    

Ordinary income

  $ 100,052      $ 17,405  
 

 

 

    

 

 

 

Evolved U.S. Media and Entertainment

    

Ordinary income

  $ 81,138      $ 11,735  
 

 

 

    

 

 

 

Evolved U.S. Technology

    

Ordinary income

  $ 74,296      $ 10,692  
 

 

 

    

 

 

 

 

 

NOTES TO FINANCIAL STATEMENTS      59  


Notes to Financial Statements  (continued)

 

As of July 31, 2019, the tax components of accumulated net earnings (losses) were as follows:

 

iShares ETF   Undistributed    
Ordinary Income    
     Undistributed
Long-Term Capital Gains
     Non-expiring   
Capital Loss   
Carryforwards(a)
     Net Unrealized   
Gains (Losses)(b)
     Total      

Evolved U.S. Consumer Staples

  $ 15,887          $ 1,118          $ —          $ 416,347          $ 433,352      

Evolved U.S. Discretionary Spending

    10,513            12,576            —            914,463            937,552      

Evolved U.S. Financials

    9,078            —            (44,341)           68,278            33,015      

Evolved U.S. Healthcare Staples

    71,622            1,480            —            770,952            844,054      

Evolved U.S. Innovative Healthcare

    35,335            48,469            —            (53,253)           30,551      

Evolved U.S. Media and Entertainment

    186,839            16,940            —            524,933            728,712      

Evolved U.S. Technology

    15,719            12,785            —            1,372,484            1,400,988      

 

  (a)

Amounts available to offset future realized capital gains.

  (b)

The difference between book-basis and tax-basis unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales and the characterization of corporate actions.

As of July 31, 2019, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

iShares ETF   Tax Cost      Gross Unrealized
Appreciation
     Gross Unrealized
Depreciation
    Net Unrealized
Appreciation
(Depreciation)
 

Evolved U.S. Consumer Staples

  $ 3,744,192      $ 665,716      $ (249,369   $ 416,347  

Evolved U.S. Discretionary Spending

    5,004,630        1,156,101        (241,638     914,463  

Evolved U.S. Financials

    4,898,862        373,162        (304,884     68,278  

Evolved U.S. Healthcare Staples

    6,839,942        915,616        (144,664     770,952  

Evolved U.S. Innovative Healthcare

    5,184,089        530,768        (584,021     (53,253

Evolved U.S. Media and Entertainment

    6,616,691        832,789        (307,856     524,933  

Evolved U.S. Technology

    15,224,098        1,511,257        (138,773     1,372,484  

 

8.  

PRINCIPAL RISKS

In the normal course of business, each Fund invests in securities or other instruments and may enter into certain transactions, and such activities subject the Fund to various risks, including, among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate or price fluctuations. Each Fund’s prospectus provides details of the risks to which the Fund is subject.

Market Risk: Market risk arises mainly from uncertainty about future values of financial instruments influenced by price, currency and interest rate movements. It represents the potential loss a fund may suffer through holding market positions in the face of market movements. A fund is exposed to market risk by its investment in equity, fixed income and/or financial derivative instruments or by its investment in underlying funds. The fair value of securities held by a fund may decline due to general market conditions, economic trends or events that are not specifically related to the issuers of the securities including local, regional or global political, social or economic instability or to factors that affect a particular industry or group of industries. The extent of a fund’s exposure to market risk is the market value of the investments held as shown in the fund’s schedule of investments.

Credit Risk: Credit risk is the risk that an issuer or guarantor of debt instruments or the counterparty to a financial transaction, including derivatives contracts, repurchase agreements or loans of portfolio securities, is unable or unwilling to make timely interest and/or principal payments or to otherwise honor its obligations. BFA and its affiliates manage counterparty credit risk by entering into transactions only with counterparties that they believe have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose a fund to issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of a fund’s exposure to credit and counterparty risks with respect to those financial assets is approximated by their value recorded in its statement of assets and liabilities.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within each Fund’s portfolio are disclosed in its schedule of investments.

When a fund concentrates its investments in securities within a single or limited number of market sectors, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the fund and could affect the income from, or the value or liquidity of, the fund’s portfolio.

 

9.  

CAPITAL SHARE TRANSACTIONS

Capital shares are issued and redeemed by each Fund only in aggregations of a specified number of shares or multiples thereof (“Creation Units”) at NAV. Except when aggregated in Creation Units, shares of each Fund are not redeemable.

 

 

60    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Notes to Financial Statements  (continued)

 

Transactions in capital shares were as follows:

 

 

 
     Year Ended
07/31/19
              Period Ended
07/31/18
 
iShares ETF    Shares        Amount               Shares        Amount  

 

 

Evolved U.S. Consumer Staples

                    

Shares sold

            $             200,000        $ 4,923,212  

Shares redeemed

                          (50,000        (1,211,775
  

 

 

      

 

 

         

 

 

      

 

 

 

Net increase

            $             150,000        $ 3,711,437  
  

 

 

      

 

 

         

 

 

      

 

 

 

Evolved U.S. Discretionary Spending

                    

Shares sold

            $             200,000        $ 4,956,981  
  

 

 

      

 

 

         

 

 

      

 

 

 

Evolved U.S. Financials

                    

Shares sold

            $             200,000        $ 4,938,160  
  

 

 

      

 

 

         

 

 

      

 

 

 

Evolved U.S. Healthcare Staples

                    

Shares sold

     100,000        $ 2,773,961             200,000        $ 4,960,601  

Shares redeemed

     (50,000        (1,338,232                     
  

 

 

      

 

 

         

 

 

      

 

 

 

Net increase

     50,000        $ 1,435,729             200,000        $ 4,960,601  
  

 

 

      

 

 

         

 

 

      

 

 

 

Evolved U.S. Innovative Healthcare

                    

Shares sold

            $             200,000        $ 4,918,256  
  

 

 

      

 

 

         

 

 

      

 

 

 

Evolved U.S. Media and Entertainment

                    

Shares sold

     50,000        $ 1,347,171             200,000        $ 4,979,943  
  

 

 

      

 

 

         

 

 

      

 

 

 

Evolved U.S. Technology

                    

Shares sold

     350,000        $ 10,161,391             200,000        $ 4,907,809  
  

 

 

      

 

 

         

 

 

      

 

 

 

The consideration for the purchase of Creation Units of a fund in the Trust generally consists of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Certain funds in the Trust may be offered in Creation Units solely or partially for cash in U.S. dollars. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to State Street Bank and Trust Company, the Trust’s administrator, to offset transfer and other transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. Investors transacting in Creation Units for cash may also pay an additional variable charge to compensate the relevant fund for certain transaction costs (i.e., stamp taxes, taxes on currency or other financial transactions, and brokerage costs) and market impact expenses relating to investing in portfolio securities. Such variable charges, if any, are included in shares sold in the table above.

From time to time, settlement of securities related to in-kind contributions or in-kind redemptions may be delayed. In such cases, securities related to in-kind transactions are reflected as a receivable or a payable in the statement of assets and liabilities.

 

10.

LEGAL PROCEEDINGS

On June 16, 2016, investors in certain iShares funds (iShares Core S&P Small-Cap ETF, iShares Russell 1000 Growth ETF, iShares Core S&P 500 ETF, iShares Russell Mid-Cap Growth ETF, iShares Russell Mid-Cap ETF, iShares Russell Mid-Cap Value ETF, iShares Select Dividend ETF, iShares Morningstar Mid-Cap ETF, iShares Morningstar Large-Cap ETF, iShares U.S. Aerospace & Defense ETF and iShares Preferred and Income Securities ETF) filed a class action lawsuit against iShares Trust, BlackRock, Inc. and certain of its advisory affiliates, and certain directors/trustees and officers of the Funds (collectively, “Defendants”) in California State Court. The lawsuit alleges the Defendants violated federal securities laws by failing to adequately disclose in the prospectuses issued by the funds noted above the risks of using stop-loss orders in the event of a ‘flash crash’, such as the one that occurred on May 6, 2010. On September 18, 2017, the court issued a Statement of Decision holding that the Plaintiffs lack standing to assert their claims. On October 11, 2017, the court entered final judgment dismissing all of the Plaintiffs’ claims with prejudice. Plaintiffs have appealed the court’s decision.

 

11.

REGULATION S-X AMENDMENTS

On August 17, 2018, the SEC adopted amendments to certain disclosure requirements in Securities Act Release No. 33-10532, Disclosure Update and Simplification. The Funds have adopted the amendments pertinent to Regulation S-X in this shareholder report. The amendments impacted certain disclosure presentation on the statement of assets and liabilities, statement of changes in net assets and notes to the financial statements.

Prior year distribution information and undistributed net investment income in the statement of changes in net assets has been modified to conform to the current year presentation in accordance with the Regulation S-X changes.

 

 

NOTES TO FINANCIAL STATEMENTS      61  


Notes to Financial Statements  (continued)

 

Distributions for the period ended July 31, 2018 were classified as follows:

 

iShares ETF    Net
Investment Income
 

Evolved U.S. Consumer Staples

   $ 32,423  

Evolved U.S. Discretionary Spending

     18,716  

Evolved U.S. Financials

     21,657  

Evolved U.S. Healthcare Staples

     11,128  

Evolved U.S. Innovative Healthcare

     17,405  

Evolved U.S. Media and Entertainment

     11,735  

Evolved U.S. Technology

     10,692  

Undistributed net investment income as of July 31, 2018 are as follows:

 

iShares ETF    Undistributed
net investment income
 

Evolved U.S. Consumer Staples

   $ 25,529  

Evolved U.S. Discretionary Spending

     3,903  

Evolved U.S. Financials

     6,588  

Evolved U.S. Healthcare Staples

     4,865  

Evolved U.S. Innovative Healthcare

     4,177  

Evolved U.S. Media and Entertainment

     6,833  

Evolved U.S. Technology

     1,866  

 

12.

SUBSEQUENT EVENTS

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were available to be issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

 

 

62    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Report of Independent Registered Public Accounting Firm

 

To the Board of Trustees of iShares U.S. ETF Trust and

Shareholders of iShares Evolved U.S. Consumer Staples ETF,

iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF,

iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF,

iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Technology ETF

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF, iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Technology ETF (seven of the funds constituting iShares U.S. ETF Trust, hereafter collectively referred to as the “Funds”) as of July 31, 2019, the related statements of operations for the year ended July 31, 2019 and the statement of changes in net assets and the financial highlights for the year ended July 31, 2019 and for the period March 21, 2018 (commencement of operations) to July 31, 2018, including the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of July 31, 2019, the results of each of their operations for the year ended July 31, 2019, and the changes in each of their net assets and each of their financial highlights for the year ended July 31, 2019 and for the period March 21, 2018 (commencement of operations) to July 31, 2018 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of July 31, 2019 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

September 20, 2019

We have served as the auditor of one or more BlackRock investment companies since 2000.

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM      63  


Important Tax Information  (unaudited)

 

For corporate shareholders, the percentage of ordinary income distributions paid during the fiscal year ended July 31, 2019 that qualified for the dividends-received deduction were as follows:

 

iShares ETF   Dividends-Received
Deduction
 

Evolved U.S. Consumer Staples

    88.96

Evolved U.S. Discretionary Spending

    84.47

Evolved U.S. Financials

    100.00

Evolved U.S. Healthcare Staples

    29.73

Evolved U.S. Innovative Healthcare

    75.09

Evolved U.S. Media and Entertainment

    23.03

Evolved U.S. Technology

    72.58

The following maximum amounts are hereby designated as qualified dividend income for individuals for the fiscal year ended July 31, 2019:

 

iShares ETF   Qualified Dividend
Income
 

Evolved U.S. Consumer Staples

  $ 104,805  

Evolved U.S. Discretionary Spending

    85,702  

Evolved U.S. Financials

    106,056  

Evolved U.S. Healthcare Staples

    53,616  

Evolved U.S. Innovative Healthcare

    79,512  

Evolved U.S. Media and Entertainment

    60,513  

Evolved U.S. Technology

    66,363  

The following distribution amounts are hereby designated for the fiscal year ended July 31, 2019:

 

iShares ETF   Short-Term
Capital Gain
Dividends
     20% Rate
Long-Term
Capital Gain
Dividends
 

Evolved U.S. Consumer Staples

  $ 8,485      $  

Evolved U.S. Discretionary Spending

    10,791         

Evolved U.S. Healthcare Staples

    23,251        126  

Evolved U.S. Innovative Healthcare

    28,999         

Evolved U.S. Media and Entertainment

    26,740         

Evolved U.S. Technology

    15,869         

 

 

64    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Board Review and Approval of Investment Advisory Contract

 

iShares U.S. ETF Trust

iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Financials ETF, iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Media And Entertainment ETF, iShares Evolved U.S.Technology ETF (the “Funds”)

Under Section 15(c) of the Investment Company Act of 1940 (the “1940 Act”), the Trust’s Board of Trustees (the “Board”), including a majority of Trustees who are not “interested persons” of the Trust (as that term is defined in the 1940 Act) (the “Independent Trustees”), is required annually to consider and approve the Investment Advisory Contract between the Trust and BFA (the “Advisory Contract”) on behalf of the Funds. The Board’s consideration entails a year-long process whereby the Board and its committees (composed solely of Independent Trustees) assess BlackRock’s services to the Funds, including investment management; fund accounting; administrative and shareholder services; oversight of the Funds’ service providers; risk management and oversight; legal and compliance services; and ability to meet applicable legal and regulatory requirements. The Independent Trustees requested, and BFA provided, such information as the Independent Trustees, with advice from independent counsel, deemed reasonably necessary to evaluate the Advisory Contract. At meetings on May 6, 2019 and May 17, 2019, a committee composed of all of the Independent Trustees (the “15(c) Committee”), with independent counsel, met with management and reviewed and discussed information provided in response to initial requests of the 15(c) Committee and/or their independent counsel, and requested certain additional information, which management agreed to provide. At a meeting held on June 17-19, 2019, the Board, including the Independent Trustees, reviewed the additional information provided by management in response to these requests.

After extensive discussions and deliberations, the Board, including all of the Independent Trustees, approved the continuance of the Advisory Contract for the Funds, based on a review of qualitative and quantitative information provided by BFA and their cumulative experience as Trustees. The Board noted its satisfaction with the extent and quality of information provided and its frequent interactions with management, as well as the detailed responses and other information provided by BFA. The Independent Trustees were advised by their independent counsel throughout the process, including about the legal standards applicable to their review. In approving the Advisory Contract for the Funds, the Board, including the Independent Trustees, considered various factors, including: (i) the expenses and performance of each Fund; (ii) the nature, extent and quality of the services provided by BFA; (iii) the costs of services provided to each Fund and profits realized by BFA and its affiliates; (iv) economies of scale; (v) the fees and services provided for other comparable funds/accounts managed by BFA and its affiliates; and (vi) other benefits to BFA and/or its affiliates. The material factors, no one of which was controlling, and conclusions that formed the basis for the Board, including the Independent Trustees, to approve the Advisory Contract are discussed below.

Expenses and Performance of the Funds: The Board reviewed statistical information prepared by Broadridge Financial Solutions Inc. (“Broadridge”), an independent provider of investment company data, regarding the expense ratio components, including gross and net total expenses, fees and expenses of another fund in which each Fund invests (if applicable), and waivers/reimbursements (if applicable) of each Fund in comparison with the same information for other ETFs (including, where applicable, funds sponsored by an “at cost” service provider), objectively selected by Broadridge as comprising each Fund’s applicable peer group pursuant to Broadridge’s proprietary ETF methodology (the “Peer Group”). The Board was provided with a detailed description of the proprietary ETF methodology used by Broadridge to determine the applicable Peer Groups. The Board further noted that due to the limitations in providing comparable funds in the various Peer Groups, the statistical information provided in Broadridge’s report may or may not provide meaningful direct comparisons to the Funds in all instances.

The Board also noted that the investment advisory fee rates and overall expenses (net of any waivers and reimbursements) for the Funds were lower than the median of the investment advisory fee rates and overall expenses (net of any waivers and reimbursements) of the funds in their respective Peer Group, excluding iShares funds. In addition, to the extent that any of the comparison funds included in the Peer Group, excluding iShares funds, track the same index as any particular Fund, Broadridge also provided, and the Board reviewed, a comparison of such Fund’s performance for the one-, three-, five-, ten-year, and since inception periods, as applicable, and for the quarter ended December 31, 2018, to that of relevant comparison fund(s) for the same periods. The Board noted that each Fund is an actively managed ETF that does not seek to track the performance of a specified index and that the management team for each Fund manages its portfolio in accordance with its investment objective. The Board further noted that, during the year, the Board received periodic reports on each Fund’s short- and longer-term performance in comparison with its reference benchmark. Such periodic comparative performance information, including additional detailed information as requested by the Board, was also considered. The Board noted that each Fund generally performed in line with expectations relative to its respective reference benchmark.

Based on this review, the other factors considered at the meeting, and their general knowledge of ETF pricing, the Board concluded that the investment advisory fee rate and expense level and the historical performance of each Fund supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Nature, Extent and Quality of Services Provided by BFA: Based on management’s representations, including information about recent and proposed enhancements to the iShares business, including with respect to capital markets support and analysis, technology, portfolio management, product design and quality, compliance and risk management, global public policy and other services, the Board expected that there would be no diminution in the scope of services required of or provided by BFA under the Advisory Contract for the coming year as compared to the scope of services provided by BFA during prior years. In reviewing the scope of these services, the Board considered BFA’s investment philosophy and experience, noting that BFA and its affiliates have committed significant resources over time, including during the past year, to support the iShares funds and their shareholders and have made significant investments into the iShares business. The Board also considered BFA’s compliance program and its compliance record with respect to the Funds. In that regard, the Board noted that BFA reports to the Board about portfolio management and compliance matters on a periodic basis in connection with regularly scheduled meetings of the Board, and on other occasions as necessary and appropriate, and has provided information and made relevant officers and other employees of BFA (and its affiliates) available as needed to provide further assistance with these matters. The Board also reviewed the background and experience of the persons responsible for the day-to-day management of the Funds, as well as the resources available to them in managing

 

 

BOARD REVIEW AND APPROVAL OF INVESTMENT ADVISORY CONTRACT      65  


Board Review and Approval of Investment Advisory Contract  (continued)

 

the Funds. In addition to the above considerations, the Board reviewed and considered detailed presentations regarding BFA’s investment performance, investment and risk management processes and strategies provided at the June 17-19, 2019 meeting and throughout the year.

Based on review of this information, and the performance information discussed above, the Board concluded that the nature, extent and quality of services provided to the Funds under the Advisory Contract supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Costs of Services Provided to the Funds and Profits Realized by BFA and its Affiliates: The Board reviewed information about the estimated profitability to BlackRock in managing the Funds, based on the fees payable to BFA and its affiliates (including fees under the Advisory Contract), and other sources of revenue and expense to BFA and its affiliates from the Funds’ operations for the last calendar year. The Board reviewed BlackRock’s methodology for calculating estimated profitability of the iShares funds, noting that the 15(c) Committee and the Board had focused on the methodology and profitability presentation during their meetings. The Board recognized that profitability may be affected by numerous factors including, among other things, fee waivers by the Adviser, the types of funds managed, expense allocations and business mix. The Board thus recognized that calculating and comparing profitability at individual fund levels is challenging. The Board discussed the sources of direct and ancillary revenue with management, including the revenues to BTC, a BlackRock affiliate, from securities lending by the Funds. The Board also discussed BFA’s estimated profit margin as reflected in the Funds’ profitability analysis and reviewed information regarding potential economies of scale (as discussed below).

Based on this review, the Board concluded that the profits realized by BFA and its affiliates under the Advisory Contract and from other relationships between the Funds and BFA and/or its affiliates, if any, were within a reasonable range in light of the factors and other information considered.

Economies of Scale: The Board reviewed information and considered the extent to which economies of scale might be realized as the assets of the Funds increase, noting that the issue of potential economies of scale had been focused on by the 15(c) Committee and the Board during their meetings and addressed by management. The 15(c) Committee and the Board received information regarding BlackRock’s historical estimated profitability, including BFA’s and its affiliates’ estimated costs in providing services, noting that such costs have increased over the past year. The estimated cost information distinguished, among other things, between fixed and variable costs, and showed how the level and nature of fixed and variable costs may impact the existence or size of scale benefits, with the Board recognizing that potential economies of scale are difficult to measure. The 15(c) Committee and the Board reviewed information provided by BFA regarding the sharing of scale benefits with the iShares funds through various means, including, as applicable, through relatively low fee rates established at inception, breakpoints, waivers, or other fee reductions, as well as through additional investment in the iShares business and the provision of improved or additional infrastructure and services to the iShares funds and their shareholders. The Board noted that the Advisory Contract for the Funds did not provide for breakpoints in the Funds’ investment advisory fee rate as the assets of the Funds increase. However, the Board would continue to assess the appropriateness of adding breakpoints in the future.

The Board concluded that this review of potential economies of scale and the sharing of related benefits, as well as the other factors considered at the meeting, supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Fees and Services Provided for Other Comparable Funds/Accounts Managed by BFA and its Affiliates: The Board considered information regarding the investment advisory/management fee rates for other funds/accounts in the U.S. for which BFA (or its affiliates) provides investment advisory/management services, including open-end funds registered under the 1940 Act (including sub-advised funds), collective trust funds, and institutional separate accounts (collectively, the “Other Accounts”). The Board acknowledged BFA’s representation that the iShares funds are fundamentally different investment vehicles from the Other Accounts. The Board noted that BFA and its affiliates do not manage Other Accounts with a similar investment strategies or investment mandates as the Funds. The Board further noted that BFA provided the Board with detailed information regarding how the Other Accounts generally differ from the Funds, including in terms of the types of services and generally more extensive services provided to the Funds, as well as other significant differences. In that regard, the Board considered that the pricing of services to institutional clients is typically based on a number of factors beyond the nature and extent of the specific services to be provided and often depends on the overall relationship between the client and its affiliates and the adviser and its affiliates. In addition, the Board considered the relative complexity and inherent risks and challenges of managing and providing other services to the Funds, as a publicly traded ETFs, as compared to the Other Accounts, particularly those that are institutional clients, in light of differing regulatory requirements and client-imposed mandates. The Board also acknowledged management’s assertion that, for certain iShares funds, and for client segmentation purposes, BlackRock has launched an iShares fund that may provide a similar investment exposure at a lower investment advisory fee rate. The Board also considered the “all-inclusive” nature of the Funds’ advisory fee structure, and the Funds’ expenses borne by BFA under this arrangement. The Board noted that the investment advisory fee rates under the Advisory Contract for the Funds was generally higher than the investment advisory/management fee rates for certain of the Other Accounts (particularly institutional clients) and concluded that the differences appeared to be consistent with the factors discussed.

Other Benefits to BFA and/or its Affiliates: The Board reviewed other benefits or ancillary revenue received by BFA and/or its affiliates in connection with the services provided to the Funds by BFA, both direct and indirect, such as payment of revenue to BTC, the Funds’ securities lending agent, for loaning portfolio securities (which was included in the profit margins reviewed by the Board pursuant to BFA’s estimated profitability methodology), payment of advisory fees or other fees to BFA (or its affiliates) in connection with any investments by the Funds in other funds for which BFA (or its affiliates) provides investment advisory services or other services and BlackRock’s increased profile in the investment community. The Board also noted the revenue received by BFA and/or its affiliates pursuant to an agreement that permits a service provider to use certain portions of BlackRock’s technology platform to service accounts managed by BFA and/or its affiliates, including the iShares funds. The Board noted that BFA generally does not use soft dollars or consider the value of research or other services that may be provided to BFA (including its affiliates) in selecting brokers for portfolio transactions for the Funds. The Board further noted that any portfolio transactions on behalf of the Funds placed through a BFA affiliate or purchased from an underwriting syndicate in which a BFAaffiliate participates (including associated commissions) are reported to the Board pursuant to Rule 17e-1 or Rule 10f-3, as applicable, under the 1940 Act. The Board concluded that any such ancillary benefits would not be disadvantageous to the Funds and thus would not alter the Board’s conclusion with respect to the appropriateness of approving the continuance of the Advisory Contract for the coming year.

Conclusion: Based on a review of the factors described above, as well as such other factors as deemed appropriate by the Board, the Board, including all of the Independent Trustees, determined that the Funds’ investment advisory fee rates under the Advisory Contract do not constitute fees that are so disproportionately large as

 

 

66    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Board Review and Approval of Investment Advisory Contract  (continued)

 

to bear no reasonable relationship to the services rendered and that could not have been the product of arm’s-length bargaining, and concluded to approve the continuance of the Advisory Contract for the coming year.

 

 

BOARD REVIEW AND APPROVAL OF INVESTMENT ADVISORY CONTRACT      67  


Supplemental Information  (unaudited)

 

Section 19(a) Notices

The amounts and sources of distributions reported are estimates and are being provided pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources for tax reporting purposes will depend upon each fund’s investment experience during the year and may be subject to changes based on tax regulations. Shareholders will receive a Form 1099-DIV each calendar year that will inform them how to report these distributions for federal income tax purposes.

 

   
    Total Cumulative Distributions
for the Fiscal Year
          % Breakdown of the Total Cumulative
Distributions for the Fiscal Year
 
iShares ETF   Net
Investment
Income
    Net Realized
Capital Gains
    Return of
Capital
    Total Per
Share
          Net
Investment
Income
    Net Realized
Capital Gains
    Return of
Capital
    Total Per
Share
 
   

Evolved U.S. Consumer Staples(a)

  $ 0.770527     $ 0.056567     $  0.075051     $ 0.902145         86     6     8     100

Evolved U.S. Discretionary Spending(a)

    0.389684              0.074689       0.464373         84             16       100  

Evolved U.S. Financials(a)

    0.497027              0.003689       0.500716         99             1       100  

Evolved U.S. Healthcare Staples(a)

    0.354146              0.046766       0.400912         88             12       100  

Evolved U.S. Innovative Healthcare

    0.355266       0.144995             0.500261         71       29             100  

Evolved U.S. Media and Entertainment(a)

    0.258298       0.133700        0.001342       0.393340         66       34       0 (b)      100  

Evolved U.S. Technology(a)

    0.274992              0.061237       0.336229         82             18       100  
   

 

  (a)

The Fund estimates that it has distributed more than its net investment income and net realized capital gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment in the Fund is returned to the shareholder. A return of capital does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”. When distributions exceed total return performance, the difference will incrementally reduce the Fund’s net asset value per share.

 
  (b) 

Rounds to less than 1%.

 

Premium/Discount Information

The Premium/Discount Information section is intended to present information about the differences between the daily market price on secondary markets for shares of a fund and that fund’s NAV. NAV is the price at which a fund issues and redeems shares. It is calculated in accordance with the standard formula for valuing mutual fund shares. The “Market Price” of a fund generally is determined using the midpoint between the highest bid and the lowest ask on the primary securities exchange on which shares of such fund are listed for trading, as of the time that the fund’s NAV is calculated. A fund’s Market Price may be at, above or below its NAV. The NAV of a fund will fluctuate with changes in the value of its portfolio holdings. The Market Price of a fund will fluctuate in accordance with changes in its NAV, as well as market supply and demand.

Premiums or discounts are the differences (expressed as a percentage) between the NAV and Market Price of a fund on a given day, generally at the time the NAV is calculated. A premium is the amount that a fund is trading above the reported NAV, expressed as a percentage of the NAV. A discount is the amount that a fund is trading below the reported NAV, expressed as a percentage of the NAV.

Premium/discount information for the Funds covering the most recently completed calendar year and the most recently completed calendar quarters since that year (or since the Fund began trading, if shorter) is publicly accessible, free of charge, at www.iShares.com.

The following information shows the frequency of distributions of premiums and discounts for the Funds for the immediately preceding five calendar years (or from the date a Fund began trading on the secondary market, if less than five years) through the date of the most recent calendar quarter-end. Each line in each table shows the number of trading days in which the Fund traded within the premium/discount range indicated. Premium/discount ranges with no trading days are omitted. The number of trading days in each premium/discount range is also shown as a percentage of the total number of trading days in the period covered by each table. All data presented here represents past performance, which cannot be used to predict future results.

iShares Evolved U.S. Consumer Staples ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range    Number
of Days
       Percentage of
Total Days
 

Greater than 1.0% and Less than 1.5%

     1          0.31

Greater than 0.0% and Less than 0.5%

     260          81.51  

At NAV

     18          5.64  

Less than 0.0% and Greater than –0.5%

     40          12.54  
  

 

 

      

 

 

 
     319          100.00
  

 

 

      

 

 

 

 

 

68    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Supplemental Information  (unaudited) (continued)

 

iShares Evolved U.S. Discretionary Spending ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 0.5% and Less than 1.0%

    1        0.31

Greater than 0.0% and Less than 0.5%

    148        46.39  

At NAV

    20        6.27  

Less than 0.0% and Greater than –0.5%

    149        46.72  

Less than –1.0% and Greater than –1.5%

    1        0.31  
 

 

 

    

 

 

 
    319        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Financials ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 2.0% and Less than 2.5%

    1        0.31

Greater than 0.0% and Less than 0.5%

    200        62.70  

At NAV

    27        8.46  

Less than 0.0% and Greater than –0.5%

    91        28.53  
 

 

 

    

 

 

 
    319        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Healthcare Staples ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 2.0% and Less than 2.5%

    1        0.31

Greater than 0.0% and Less than 0.5%

    213        66.77  

At NAV

    22        6.90  

Less than 0.0% and Greater than –0.5%

    83        26.02  
 

 

 

    

 

 

 
    319        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Innovative Healthcare ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 0.0% and Less than 0.5%

    220        68.96

At NAV

    31        9.72  

Less than 0.0% and Greater than –0.5%

    68        21.32  
 

 

 

    

 

 

 
    319        100.00
 

 

 

    

 

 

 

iShares Evolved U.S. Media and Entertainment ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 0.0% and Less than 0.5%

    184        57.68

At NAV

    25        7.84  

Less than 0.0% and Greater than –0.5%

    110        34.48  
 

 

 

    

 

 

 
    319        100.00
 

 

 

    

 

 

 

 

 

SUPPLEMENTAL INFORMATION      69  


Supplemental Information  (unaudited) (continued)

 

iShares Evolved U.S. Technology ETF

Period Covered: March 23, 2018 through June 30, 2019

 

Premium/Discount Range   Number
of Days
     Percentage of
Total Days
 

Greater than 1.0% and Less than 1.5%

    1        0.31

Greater than 0.0% and Less than 0.5%

    263        82.45  

At NAV

    14        4.39  

Less than 0.0% and Greater than –0.5%

    41        12.85  
 

 

 

    

 

 

 
    319        100.00
 

 

 

    

 

 

 

 

 

70    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


Trustee and Officer Information

 

The Board of Trustees has responsibility for the overall management and operations of the Funds, including general supervision of the duties performed by BFA and other service providers. Each Trustee serves until he or she resigns, is removed, dies, retires or becomes incapacitated. The President, Chief Compliance Officer, Treasurer and Secretary shall each hold office until their successors are chosen and qualify, and all other officers shall hold office until he or she resigns or is removed. Trustees who are not “interested persons” (as defined in the 1940 Act) of the Trust are referred to as independent trustees (“Independent Trustees”).

The registered investment companies advised by BFAor its affiliates (the “BlackRock-advised Funds”) are organized into one complex of open-end equity, multi-asset, index and money market funds (the “BlackRock Multi-Asset Complex”), one complex of closed-end funds and open-end non-index fixed-income funds (the “BlackRock Fixed-Income Complex”) and one complex of exchange-traded funds (“Exchange-Traded Fund Complex”) (each, a “BlackRock Fund Complex”). Each Fund is included in the BlackRock Fund Complex referred to as the Exchange-Traded Fund Complex. Each Trustee also serves as a Director of iShares, Inc. and a Trustee of iShares Trust, and, as a result, oversees all of the funds within the Exchange-Traded Fund Complex, which consists of 360 funds as of July 31, 2019. With the exception of Robert S. Kapito, Salim Ramji, Charles Park, Martin Small and Neal J. Andrews, the address of each Trustee and officer is c/o BlackRock, Inc., 400 Howard Street, San Francisco, CA94105. The address of Mr. Kapito, Mr. Ramji, Mr. Park, Mr. Small and Mr. Andrews is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. The Board has designated Cecilia H. Herbert as its Independent Board Chair. Additional information about the Funds’ Trustees and officers may be found in the Funds’ combined Statement of Additional Information, which is available without charge, upon request, by calling toll-free 1-800-iShares (1-800-474-2737).

 

Interested Trustees
       
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee

Robert S. Kapito(a)

(62)

  

Trustee (since

2011).

   President, BlackRock, Inc. (since 2006); Vice Chairman of BlackRock, Inc. and Head of BlackRock’s Portfolio Management Group (since its formation in 1998) and BlackRock, Inc.’s predecessor entities (since 1988); Trustee, University of Pennsylvania (since 2009); President of Board of Directors, Hope & Heroes Children’s Cancer Fund (since 2002).    Director of BlackRock, Inc. (since 2006); Director of iShares, Inc. (since 2009); Trustee of iShares Trust (since 2009).

Salim Ramji(b)

(49)

  

Trustee (since

2019).

   Senior Managing Director, BlackRock, Inc. (since 2014); Global Head of BlackRock’s ETF and Index Investments Business (since 2019); Head of BlackRock’s U.S. Wealth Advisory Business (2015-2019); Global Head of Corporate Strategy, BlackRock, Inc. (2014-2015); Senior Partner, McKinsey & Company (2010-2014).    Director of iShares, Inc. (since 2019); Trustee of iShares Trust (since 2019).

(a) Robert S. Kapito is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

(b) Salim Ramji is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

 

Independent Trustees
       
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee

Cecilia H. Herbert

(70)

  

Trustee (since

2011);

Independent

Board Chair

(since 2016).

   Chair of the Finance Committee (since 2019) and Trustee and Member of the Finance, Technology and Quality Committees of Stanford Health Care (since 2016); Member of the Audit Committee (since 2018) and Trustee and Member of the Investment Committee, WNET, a New York public media company (since 2011); Chair (1994-2005) and Member (since 1992) of the Investment Committee, Archdiocese of San Francisco; Trustee of Forward Funds (14 portfolios) (2009-2018); Trustee of Salient MF Trust (4 portfolios) (2015-2018); Director (1998-2013) and President (2007-2011) of the Board of Directors, Catholic Charities CYO; Trustee (2002-2011) and Chair of the Finance and Investment Committee (2006-2010) of the Thacher School.    Director of iShares, Inc. (since 2005); Trustee of iShares Trust (since 2005); Independent Board Chair of iShares, Inc. and iShares Trust (since 2016); Trustee of Thrivent Church Loan and Income Fund (since 2019).

Jane D. Carlin

(63)

  

Trustee (since

2015); Risk

Committee Chair

(since 2016).

   Consultant (since 2012); Member of the Audit Committee (2012-2018), Chair of the Nominating and Governance Committee (2017-2018) and Director of PHH Corporation (mortgage solutions) (2012-2018); Managing Director and Global Head of Financial Holding Company Governance & Assurance and the Global Head of Operational Risk Management of Morgan Stanley (2006-2012).    Director of iShares, Inc. (since 2015); Trustee of iShares Trust (since 2015); Member of the Audit Committee (since 2016) and Director of The Hanover Insurance Group, Inc. (since (2016).

Richard L. Fagnani

(64)

  

Trustee (since

2017); Audit

Committee Chair

(since 2019).

   Partner, KPMG LLP (2002-2016).    Director of iShares, Inc. (since 2017); Trustee of iShares Trust (since 2017).

 

 

TRUSTEE AND OFFICER INFORMATION      71  


Trustee and Officer Information  (continued)

 

Independent Trustees (continued)
       
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee

John E. Kerrigan

(64)

  

Trustee (since

2011); Nominating

and Governance

and Equity Plus

Committee Chairs

(since 2019).

   Chief Investment Officer, Santa Clara University (since 2002).    Director of iShares, Inc. (since 2005); Trustee of iShares Trust (since 2005).

Drew E. Lawton

(60)

  

Trustee (since

2017); 15(c)

Committee Chair

(since 2017).

   Senior Managing Director of New York Life Insurance Company (2010-2015).    Director of iShares, Inc. (since 2017); Trustee of iShares Trust (since 2017).

John E. Martinez

(58)

  

Trustee (since

2011); Securities

Lending

Committee Chair

(since 2019).

   Director of Real Estate Equity Exchange, Inc. (since 2005); Director of Cloudera Foundation (since 2017); and Director of Reading Partners (2012-2016).    Director of iShares, Inc. (since 2003); Trustee of iShares Trust (since 2003).

Madhav V. Rajan

(54)

  

Trustee (since

2011); Fixed

Income Plus

Committee Chair

(since 2019).

   Dean, and George Pratt Shultz Professor of Accounting, University of Chicago Booth School of Business (since 2017); Robert K. Jaedicke Professor of Accounting, Stanford University Graduate School of Business (2001-2017); Professor of Law (by courtesy), Stanford Law School (2005-2017); Senior Associate Dean for Academic Affairs and Head of MBA Program, Stanford University Graduate School of Business (2010-2016).    Director of iShares, Inc. (since 2011); Trustee of iShares Trust (since 2011).

 

Officers(a)
     
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

Martin Small

(44)

  

President (since

2016).

   Managing Director, BlackRock, Inc. (since 2010); Head of BlackRock’s U.S. Wealth Advisory Business (since 2019); Head of U.S. iShares (2015-2019); Co-Head of the U.S. Financial Markets Advisory Group, BlackRock, Inc. (2008-2014).

Neal J. Andrews

(53)

  

Treasurer and

Chief Financial

Officer (since

2019).

   Managing Director of BlackRock, Inc. (since 2006); Chief Financial Officer of the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex (since 2007).

Charles Park

(51)

  

Chief Compliance

Officer (since

2011).

   Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex (since 2014); Chief Compliance Officer of BFA (since 2006).

Deepa Damre

(44)

  

Secretary (since

2019).

   Managing Director, BlackRock, Inc. (since 2014); Director, BlackRock, Inc. (2009-2013).

Scott Radell

(50)

  

Executive Vice

President (since

2012).

   Managing Director, BlackRock, Inc. (since 2009); Head of Portfolio Solutions, BlackRock, Inc. (since 2009).

Alan Mason

(58)

  

Executive Vice

President (since

2016).

   Managing Director, BlackRock, Inc. (since 2009).

(a) Effective September 13, 2019, Armando Senra has replaced Martin Small as President and Marybeth Leithead has been appointed as Executive Vice President.

 

 

72    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


General Information

 

Electronic Delivery

Shareholders can sign up for email notifications announcing that the shareholder report or prospectus has been posted on the iShares website at www.iShares.com. Once you have enrolled, you will no longer receive prospectuses and shareholder reports in the mail.

To enroll in electronic delivery:

 

   

Go to www.icsdelivery.com.

 

   

If your brokerage firm is not listed, electronic delivery may not be available. Please contact your broker-dealer or financial advisor.

Householding

Householding is an option available to certain fund investors. Householding is a method of delivery, based on the preference of the individual investor, in which a single copy of certain shareholder documents can be delivered to investors who share the same address, even if their accounts are registered under different names. Please contact your broker-dealer if you are interested in enrolling in householding and receiving a single copy of prospectuses and other shareholder documents, or if you are currently enrolled in householding and wish to change your householding status.

Availability of Quarterly Schedule of Investments

The iShares Funds file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT, and for reporting periods ended prior to March 31, 2019, filed such information on Form N-Q. The iShares Funds’ Forms N-PORT and N-Q are available on the SEC’s website at www.sec.gov. The iShares Funds also disclose their complete schedule of portfolio holdings on a daily basis on the iShares website at www.iShares.com.

Availability of Proxy Voting Policies and Proxy Voting Records

A description of the policies and procedures that the iShares Funds use to determine how to vote proxies relating to portfolio securities and information about how the iShares Funds voted proxies relating to portfolio securities during the most recent twelve-month period ending June 30 is available without charge, upon request (1) by calling toll-free 1-800-474-2737; (2) on the iShares website at www.iShares.com; and (3) on the SEC website at www.sec.gov.

 

 

GENERAL INFORMATION      73  


Glossary of Terms Used in this Report

 

Portfolio Abbreviations — Equity
NVS    Non-Voting Shares

 

 

74    2019 ISHARES ANNUAL REPORT TO SHAREHOLDERS


For more information visit www.iShares.com or call 1-800-iShares (1-800-474-2737)

 

 

This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by the current prospectus.

Investing involves risk, including possible loss of principal.

The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”).

©2019 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc. or its subsidiaries. All other marks are the property of their respective owners.

iS-AR-715-0719

 

LOGO

   LOGO

 


Item 2.      Code of Ethics.

The registrant has adopted a code of ethics, as of the end of the period covered by this report, applicable to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. During the period covered by this report, the code of ethics was amended to clarify an inconsistency in to whom persons covered by the code should report suspected violations of the code. The amendment clarifies that such reporting should be made to BlackRock’s General Counsel, and retains the alternative option of anonymous reporting following “whistleblower” policies. Other non-material changes were also made in connection with this amendment. During the period covered by this report, there have been no waivers granted under the code of ethics. The registrant undertakes to provide a copy of the code of ethics to any person upon request, without charge, by calling 1-800-474-2737.

Item 3.      Audit Committee Financial Expert.

The registrant’s Board of Trustees has determined that the registrant has more than one audit committee financial expert, as that term is defined under Item 3(b) and 3(c), serving on its audit committee. The audit committee financial experts serving on the registrant’s audit committee are Richard L. Fagnani, John E. Kerrigan, and Madhav V. Rajan, all of whom are independent, as that term is defined under Item 3(a)(2).


Item 4.      Principal Accountant Fees and Services.

The principal accountant fees disclosed in items 4(a), 4(b), 4(c), 4(d) and 4(g) are for the seven series of the registrant for which the fiscal year-end is July 31, 2019 (the “Funds”), and whose annual financial statements are reported in Item 1.

 

  (a)

Audit Fees – The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the Funds’ annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years were $79,800 for the fiscal year ended July 31, 2018 and $88,900 for the fiscal year ended July 31, 2019.

 

  (b)

Audit-Related Fees – There were no fees billed for the fiscal years ended July 31, 2018 and July 31, 2019 for assurance and related services by the principal accountant that were reasonably related to the performance of the audit of the Fund’s financial statements and are not reported under (a) of this Item.

 

  (c)

Tax Fees – The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice and tax planning for the Funds were $26,467 for the fiscal year ended July 31, 2018 and $26,467 for the fiscal year ended July 31, 2019. These services related to the review of the Funds’ tax returns and excise tax calculations.

 

  (d)

All Other Fees – There were no other fees billed in each of the fiscal years ended July 31, 2018 and July 31, 2019 for products and services provided by the principal accountant, other than the services reported in (a) through (c) of this Item.

 

  (e)

(1) The registrant’s audit committee charter, as amended, provides that the audit committee is responsible for the approval, prior to appointment, of the engagement of the principal accountant to annually audit and provide their opinion on the registrant’s financial statements. The audit committee must also approve, prior to appointment, the engagement of the principal accountant to provide non-audit services to the registrant or to any entity controlling, controlled by or under common control with the registrant’s investment adviser (“Adviser Affiliate”) that provides ongoing services to the registrant, if the engagement relates directly to the operations and financial reporting of the registrant.

(2) There were no services described in (b) through (d) above that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

 

  (f)

None of the hours expended on the principal accountant’s engagement to audit the Funds’ financial statements for the fiscal year ended July 31, 2019 were attributable to work performed by persons other than the principal accountant’s full-time, permanent employees.

 

  (g)

The aggregate non-audit fees billed by the registrant’s principal accountant for services rendered to the Funds, and rendered to the registrant’s investment adviser, and any Adviser Affiliate that provides ongoing services to the registrant for the last two fiscal years were $26,467 for the fiscal year ended July 31, 2018 and $26,467 for the fiscal year ended July 31, 2019.

 

  (h)

The registrant’s audit committee has considered whether the provision of non-audit services rendered to the registrant’s investment adviser and any Adviser Affiliate that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X, if any, is compatible with maintaining the principal accountant’s independence, and has determined that the provision of these services, if any, does not compromise the principal accountant’s independence.


Item 5.      Audit Committee of Listed Registrants

(a) The registrant is a listed issuer as defined in Rule 10A-3 under the Exchange Act of 1934 and has a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act of 1934. The registrant’s audit committee members are Richard L. Fagnani, John E. Kerrigan, and Madhav V. Rajan.

(b)   Not applicable.

Item 6.      Investments.

 

  (a)

Schedules of investments are included as part of the reports to shareholders filed under Item 1 of this Form.

 

  (b)

Not applicable.

Item 7.      Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to the registrant.

Item 8.      Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to the registrant.

Item 9.      Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable to the registrant.

Item 10.    Submission of Matters to a Vote of Security Holders.

There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s Board of Trustees.

Item 11.    Controls and Procedures.

(a) The President (the registrant’s Principal Executive Officer) and Treasurer and Chief Financial Officer (the registrant’s Principal Financial Officer) have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) are effective as of a date within 90 days of the filing date of this report, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the Investment Company Act of 1940 and Rules 13a-15(b) or 15d-15(b) under the Exchange Act of 1934.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12.    Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable to the registrant.


Item 13.    Exhibits.

(a) (1) Code of Ethics is not filed as an exhibit; please refer to Item 2.

(a) (2) Section 302 Certifications are attached.

(a) (3) Not applicable.

(a) (4) Not applicable.

(b) Section 906 Certifications are attached.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

iShares U.S. ETF Trust

  By: /s/ Armando Senra                                                             

Armando Senra, President (Principal Executive Officer)

Date:        September 30, 2019

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

  By: /s/ Armando Senra                                                               

Armando Senra, President (Principal Executive Officer)

Date:        September 30, 2019

  By: /s/ Neal Andrews                                                                                          

Neal Andrews, Treasurer and Chief Financial Officer (Principal Financial Officer)

Date:        September 30, 2019